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1. Abstract    
 
Robust memory antibody responses are a distinguishing feature of humoral immunity and 
are typically marked by elevated serum immunoglobulin (Ig) titers that rapidly and 
effectively neutralize the invading pathogen. However, relatively little is known about the 
molecular mechanisms that govern the activation of memory B cells. In particular, the 
biology of IgE-expressing memory B cells remains elusive due to the scarcity of this B cell 
population, despite the clinical importance of IgE as a major driver for immediate 
hypersensitivity reactions. By analyzing human membrane bound IgE (mIgE) in B cell 
lines, this work focused on the molecular composition and signaling features of mIgE-
containing B cell antigen receptors (BCRs).  
 
A previously described mIg-intrinsic motif called the immunoglobulin tail tyrosine (ITT), 
which is exclusively present in the cytoplasmic tails of mIgG and mIgE, is known to 
augment IgG1 responses in a mouse model system. The mIgG-ITT amplifies BCR 
signaling via a Grb2-Btk complex that enhances intracellular Ca2+ mobilization. However, I 
found that unlike the mIgG-ITT which exclusively signals via the adaptor protein Grb2, the 
mIgE-ITT also employs the Grb2 related adaptor protein (Grap), which together with Grb2, 
plays an important role in mIgE-BCR signaling. The absence of these adaptor proteins 
severely impairs the capability of mIgE-BCRs to mobilize Ca2+ and activate the mitogen 
activated protein (MAP) kinase extracellular signal regulated kinase (ERK) pathway, both 
of which are central pathways for B cell activation, proliferation and differentiation. 
Therefore, by enhancing BCR signaling via the ITT-Grb2/Grap module, mIgE-BCRs lower 
the activation threshold of mIgE-expressing B cells. 
 
Furthermore, a new role for Grb2 and Grap in the canonical immunoreceptor tyrosine-
based activation motif (ITAM) signaling pathway of ITT-less BCRs was revealed, since 
mIgM-BCRs also require these proteins for optimal Ca2+ signaling. Grb2 and Grap 
contribute to ITAM-induced Ca2+ mobilization through improved activation of the Ca2+ 
initiation complex proteins Syk, SLP65 and PLC2. Therefore, Grb2 and Grap are not only 
necessary for mIgE- but also mIgM-BCR signaling in human B cells.  
 
Intriguingly, unlike the mIgM molecule, the human mIgE molecule can be expressed on 
the surface of B cells in the absence of the Ig/Ig heterodimer, a characteristic that 
depends on the cytoplasmic tail of mIgE. The mIgE-ITT motif is signaling competent in the 
absence of Ig/Ig and requires the catalytic activity of the tyrosine kinase Syk. These 
results highlight differences in signaling mechanisms employed by different BCR isotypes. 
While mIgM-expressing B cells are restricted by the Ig/Ig heterodimer for BCR 
expression and signaling, mIgE-expressing B cells can utilize the ITT motif independently 
of Ig/Ig for activation of signaling pathways. This non-canonical mIgE signaling via the 
ITT motif provides preliminary insight into novel signaling mechanisms that could be 
regulating the fate of the IgE memory and plasma B cell compartment.  
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2. Introduction  
 
2.1 The immune system of vertebrates 
 
2.1.1 The innate immune system - First line of defense against pathogens  
 
The innate arm of the immune system coordinates the early phase of an immune 
response to pathogens. For instance, the epithelial layer not only physically impedes the 
entry of pathogens but also actively secretes antimicrobial peptides like defensins 
(Selsted and Ouelette 2005). Pathogens that overcome these barriers are ingested and 
degraded by phagocytic cells like neutrophils or macrophages, in a process called 
phagocytosis (Segal 2005). Larger pathogens like helminths cannot be phagocytosed and 
are eliminated by the combined action of mast cells, basophils and eosinophils that 
secrete cytotoxic granules (Allen and Maizels 2011). The circulating complement proteins 
mediate killing of pathogens via formation of membrane attack complexes that lyse 
membranes (Zipfel and Skerka 2009).  
 
The innate immune cells do not always work alone, but also in concert with the adaptive 
immune cells, B and T lymphocytes, which express receptors that bind specifically to 
molecules called antigens (Iwasaki and Medzhitov 2015). Production of inflammatory 
cytokines by macrophages and antigen presentation by dendritic cells contribute to 
lymphocyte recruitment and activation. Conversely, antibodies work with the innate 
immune system by activating the complement system or by stimulating mast cells to 
secrete granules via immunoglobulin E (IgE)-Fc epsilon receptor (FcR) interactions. 
Natural killer cells function at the junction of innate and adaptive immunity since they can 
directly recognize and kill virus-infected cells, but are also involved in processes like 
macrophage activation and antibody-dependent cell-mediated cytotoxicity (ADCC) (Vivier 
et al 2008). Though the innate immune system is fast in its response and peaks within 
hours of infection, it lacks the capability to precisely recognize and remember its 
encounter with the antigen. In contrast, the adaptive immune system can target specific 
antigens and provide long term immunity (Janeway and Medzitov 2002). 
 
2.1.2 Adaptive immunity - the second arm of the immune system  
 
The adaptive immune system comprises B and T lymphocytes that in mammals are 
generated in the bone marrow and thymus, respectively. Upon maturation, these 
lymphocytes can either be found in secondary lymphoid organs like the spleen and lymph 
nodes, or in the blood and lymph where they scan the body for antigens. Recognition of 
the cognate antigen by these cells leads to expansion of antigen specific clones. These 
cells then effectively clear the antigen via the action of antibodies, which are secreted by 
differentiated B cells called plasma cells, or via direct cell killing by cytotoxic T cells 
(Cooper 2015, Zuniga-Pfluecker 2004).  
  Introduction 
 
 3 
2.2 Antibody mediated humoral immunity 
 
Antibodies are key weapons of the humoral immune system and are responsible for 
neutralizing and eliminating extracellular microbes. One of the first recorded instances of 
knowledge about humoral immunity dates back to China in the 1500s where smallpox 
inoculations were used to boost the immune system (now called vaccination).  It was in 
the late 1800s that antibodies were identified as the principle factor in the serum that 
targets pathogens (Von Behring and Kitasato, 1890). Since then, a lot of progress has 
been made in the structural and functional elucidation of the antibody molecule, 
culminating in the awarding of many Nobel prizes in the field. Today, besides the use of 
antibodies in research applications, targeted monoclonal antibody therapy is being used 
to treat many autoimmune disorders, allergies and cancers. The latest development in this 
regard is the use of chimeric antigen receptors (CARs) as therapy to treat B cell 
malignancies (Maude et al 2014). Thus, understanding the biology of B cell-mediated 
antibody responses can have many applications in vaccine development, cancer therapy 
and treatment of autoimmune diseases and allergies. 
 
At a functional level, secreted antibodies can initiate the elimination of the pathogen by 
neutralization, FcR-induced phagocytosis, ADCC or complement-mediated lysis. Secreted 
antibodies are produced by plasma cells, which are the terminally differentiated ‘effector’ 
B cell that are generated in a multistep process after initial recognition of the antigen by 
naïve or memory B cells. First contact with an antigen induces naïve B cells to mount a 
primary or naïve response, which is mainly dominated by the production of IgM-type 
antibodies (Yuan et al 1977). This initial burst of IgM antibodies is important for 
containment of the pathogen. Besides undergoing differentiation into IgM-secreting 
plasma cells, some naïve B cells form memory cells (Gray 1993). A fraction of memory B 
cells switch their antibody isotype to IgG, IgE or IgA and produce higher affinity antibodies 
(Honjo et al 2002, Mc-Heyzer-Williams et al 1991). Thus, re-challenge by the same 
pathogen results in a secondary or memory response, which is marked by the presence of 
large quantities of high affinity, mainly IgG antibodies in the serum that rapidly mediate the 
elimination of the pathogen (Yuan et al 1977, Hangartner et al 2006, Dogan et al 2009, 
Pape et al 2011).  
 
In order to start the process of B cell activation and differentiation, the pathogen needs to 
be specifically recognized by the cells. This is done by the membrane-bound 
immunoglobulin (mIg) molecule that is part of the B cell antigen receptor (BCR) complex 
(Reth 1992). The antigen binding region of the mIg is generated by somatic recombination 
of gene segments that encode for the mIg during B cell development in the bone marrow 
(Brack et al 1978). This process of random gene re-arrangement is called V(D)J 
recombination and is responsible for the wide diversity of antigens that can be detected by 
B cells. Binding of antigen to the BCR induces intracellular signaling cascades in the cell, 
which can lead to clonal expansion and differentiation.  
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There are two main models that explain how binding of the antigen can initiate the 
activation of downstream signaling pathways. The traditional model hypothesizes that 
binding of multivalent antigens induces crosslinking of many BCRs which are monomeric 
in the resting state. The oligomerization of the BCRs allows the activation of intracellular 
kinases, thereby kicking off BCR signaling (Metzger 1992, Tolar et al 2009). However, in 
the course of time, it was revealed that monovalent antigens can also induce intracellular 
BCR signaling (Kim et al 2006, Volkmann et al 2016). This gave rise to the so-called 
dissociation activation model, which proposes that in the resting state, mIgM- and mIgD-
BCRs are present in pre-formed oligomers in the plasma membrane. The binding of 
antigen displaces these oligomers, causing kinase induced opening of the receptor which 
culminates in intracellular BCR signaling (Schamel and Reth 2000, Yang and Reth 2010, 
Klaesner et al 2014). Regardless of these modes of activation of the BCR by antigen, the 
main intracellular signaling pathways following BCR stimulation remain the same and are 
discussed next.  
 
2.3 Antigen-induced canonical BCR signaling pathways 
 
Naïve B cells express either mIgM- and/or mIgD-BCRs on their cell surface (Havran et al 
1984). The mIgM-BCR complex comprises a mIgM molecule, associated in a 1:1 
stoichiometry with a heterodimer of two transmembrane proteins called Ig and Ig 
(Schamel and Reth 2000). This mIgM-Ig-Ig complex is assembled in the endoplasmic 
reticulum (ER) and transported to the plasma membrane only when all components are 
present and correctly assembled (Venkitaraman et al 1991, Matsuuchi et al 1992). Since 
the mIgM (and mIgD) cytoplasmic tails only contain three amino acids without any known 
signaling capabilities, antigen-induced BCR signaling begins with the phosphorylation of 
immunoreceptor tyrosine-based activation motifs (ITAMs) in the cytoplasmic domains of 
Ig and Ig (Kim et al 1993, Campbell et al 1995, Wienands et al 1996). The ITAM has a 
consensus amino acid sequence of D/ExxD/Ex7YxxI/Lx7YxxI/L (x being any amino acid) 
(Reth 1989). Binding of antigen to the mIg induces phosphorylation of the ITAM tyrosines 
by Src family tyrosine kinases like Lyn, Fyn or Blk (Tamir and Cambier 1998, Rolli et al 
2002). The two phosphorylated ITAM tyrosine residues form a perfect binding site for the 
tandem Src homology 2 (SH2) domains of spleen tyrosine kinase (Syk) (Johnsen et al 
1995, Kurosaki et al 1995). Upon binding to phosphorylated ITAMs, Syk phosphorylates a 
non-ITAM tyrosine in the C-terminus of the Ig molecule. This acts as a binding site for 
the SH2 domain of the central B cell adaptor protein SH2 domain-containing leukocyte 
protein of 65 kDa (SLP65), which in turn gets phosphorylated by Syk at multiple sites 
(Engels et al 2001, Wienands et al 1998, Zhang et al 1998). Phosphorylated SLP65 
serves as a docking point for Bruton tyrosine kinase (Btk) and its substrate 
phosphoinositide phospholipase C-gamma-2 (PLC2) (Kurosaki and Tsukada 2000). 
Together, these proteins constitute the BCR Ca2+ initiation complex. The activity of most 
of these proteins can be monitored by testing for tyrosine phosphorylation, a modification 
which in most cases activates the proteins. 
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Active PLC2 catalyzes the breakdown of membrane phosphatidylinositol-4,5-
bisphosphate (PIP2) into membrane-bound diacylglycerol (DAG) and soluble inositol-
1,4,5-trisphosphate (IP3). Binding of IP3 to a Ca
2+ channel called IP3 receptor (IP3R) on the 
ER membrane allows Ca2+ release into the cytosol. Depletion of Ca2+ in the ER is sensed 
by an ER membrane protein, stromal interaction molecule 1 (STIM1). STIM1 can directly 
induce Ca2+ entry from the extracellular space via opening of Ca2+ release activating 
channels (CRAC) channels in the plasma membrane leading to a second wave of 
cytosolic Ca2+ mobilization (Baba et al 2014, Engelke et al 2007). Intracellular Ca2+ levels 
can rapidly increase from 0.1 M to about 1 M following BCR engagement, which makes 
it one of the first measurable readouts of B cell activation. Ca2+-bound Calmodulin 
activates the phosphatase Calcineurin, which then dephosphorylates the transcription 
factor Nuclear factor of activated T cells (NFAT). Despites its name NFAT is also found in 
many cell types including B cells. Dephosphorylated NFAT translocates to the nucleus 
and induces transcriptional programs that can lead to B cell activation and differentiation 
(Mueller and Rao 2010, Winslow et al 2006, Bhattacharyya et al 2011). 
 
Another crucial signaling pathway activated downstream of the BCR is the extracellular 
signal regulated kinase (ERK)-mitogen activated protein kinase (MAPK) pathway. The 
adaptor protein Grb2 binds the guanine nucleotide exchange factor (GEF) Son of 
sevenless (Sos), which mediates the activation of the small G-protein Ras by exchanging 
guanosine diphosphate (GDP) with guanosine triphosphate (GTP). Ras-GTP activates a 
cascade of enzymes, namely Raf and dual specificity mitogen-activated protein kinase 
kinase (MEK) which finally activates ERK by phosphorylation. An alternative pathway of 
ERK activation in B cells uses Ras guanine nucleotide release protein 3 (RasGRP3), 
which is recruited to the plasma membrane by binding to DAG via its C1 domain. 
RasGRP3 catalyzes the switch to Ras-GTP, thereby initiating the ERK MAPK pathway (Li 
et al 1993, Buday et al 1994, Kumar et al 1995, Coughlin et al 2005, Roose et al 2007). B 
cell-specific deletion of ERK leads to reduced B cell survival, proliferation and 
differentiation (Yasuda et al 2008, Yasuda et al 2011). There are at least two more MAPK 
pathways that are activated upon BCR stimulation including the p38 and c-Jun N-terminal 
kinase (JNK) pathway (Sutherland et al 1996).  
 
DAG and Ca2+ also activate protein kinase C beta (PKC), which mediates activation of 
an important transcription factor family called nuclear factor kappa of activated B cells 
(NF-B) (Su et al 2002). These and other signaling pathways not mentioned here 
integrate in the nucleus (see Fig. 1), leading to a gene transcription program that decides 
the ultimate fate of the B cell - survival, proliferation, differentiation or apoptosis (Goodnow 








Figure 1: The diverse mIgM-BCR induced signaling pathways converge in the nucleus. 
Schematic illustration of the main signaling pathways induced upon mIgM-BCR engagement by an antigen. 
BCR activation leads to phosphorylation of ITAMs in the Ig/Ig heterodimer by kinases like Lyn leading to 
recruitment of Syk to phosphorylated ITAMs and assembly of the Ca
2+
 initiation complex comprising SLP65, 
Btk and PLC2. PLC2 catalyzes the production of IP3 and DAG from PIP2. IP3 induces Ca
2+
 entry into the 
cytosol from the ER and subsequently via CRAC channels from the extracellular space, culminating in 
activation of the transcription factor NFAT. DAG promotes activation of PKC which leads to NF-B activation 
and nuclear translocation. The ERK MAPK pathway can be activated by both Grb2-Sos and DAG-activated 
Ras-GRP. Co-stimulatory signals are provided by CD19 which recruits PI3K leading to activation of PKB/Akt. 
The cellular outcomes of these pathways which converge in the nucleus are specified. Cn-Calcineurin, CaM-
Calmodulin. Dashed lines represent indirect effects and solid lines represent direct effects. Purple-kinases and 
Cn phosphatase, green-adaptor proteins and Ig/Ig heterodimer, red-transcription factor, mIgM, CD19 and 
Ca
2+ 






2.4 Co-stimulatory signals support BCR signaling 
 
The intracellular signaling cascades kicked off by the BCR alone, in most cases are not 
sufficient for complete activation of the cell. This typically requires the activity of co-
stimulatory receptors. Co-stimulatory signals may be provided by T helper cells via the 
cluster of differentiation 40 (CD40)-CD40 ligand (CD40L) interaction at the immunological 
synapse between B and T cells. CD40 signaling mainly leads to the activation of NF-B 
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and thereby promotes cell survival, which can be beneficial in competitive environments 
like the germinal center (Tsubata et al 1993, Kawabe et al 1994, Mc-Heyzer Williams et al 
2012). Additionally, the CD19-CD21-CD81 trimer of transmembrane proteins also plays 
an important role in B cell activation. CD21 is a complement receptor that binds antigen-
bound complement protein C3d. This leads to crosslinking of the entire CD19-CD21-CD81 
complex to the BCR and phosphorylation of CD19, which is the signaling component of 
that complex (Fujimoto et al 2000). Phosphorylated tyrosine motifs in CD19 recruit many 
signaling proteins including Grb2, Vav and Phosphoinositide 3-kinase (PI3K) (Brooks et al 
2004). PI3K for instance, increases the local concentration of phosphatidylinositol-3,4,5-
trisphosphate (PIP3) in the plasma membrane, which helps in recruitment of signaling 
proteins like Btk, PLC2 and protein kinase B (PKB or Akt) via their Pleckstrin homology 
(PH) domains (Buhl and Cambier 1999, Jou et al 2002, Okkenhaug and Vanhaesebroeck 
2003). PKB/Akt promotes cellular processes like cell survival, growth and differentiation 
(Pogue et al 2000, Herzog et al 2009) and thereby complements BCR signaling pathways 
in determining B cell fate.  
 
2.5 Germinal centers – sites for formation of B cell memory 
 
Upon activation, naïve B cells form secondary structures in lymphoid organs called 
germinal centers (GCs) (Silva and Klein 2015). One of the main processes that occur in a 
GC is class-switching to a different Ig isotype. The first vertebrates to acquire antibodies 
were the jawed cartilaginous fish which have mainly the IgM isotype. Ig isotype switching 
did not arise until much later in evolution with amphibians being the first vertebrates to 
switch Ig class, mainly to IgY. The IgY isotype is believed to be the primordial ancestor of 
the mammalian IgG and IgE which are thought to have arisen from a gene duplication 
event (Mussmann et al 1996). IgY antibodies are present in amphibians, reptiles and also 
birds and are functionally similar to IgG (Flajnik 2002). Mammalian B cells undergo Ig 
class-switching to IgG, IgE or IgA (Honjo et al 2002). Class-switching enables the immune 
system to mount responses that are specific for a certain class of pathogen. For instance 
soluble IgG bound to viral envelope proteins that are critical for viral entry into the cell, 
may prevent this virus from infecting other cells (Hangartner et al 2006). Likewise, 
helminth-specific IgE bound to FcRs on eosinophils induces secretion of cytotoxic 
granules that kill the helminth (Allen and Maizels 2011). 
 
The second major process taking place in a GC is affinity maturation. B cells can increase 
the affinity of mIg molecules for their cognate antigen by undergoing somatic 
hypermutation (SHM) in the gene segments encoding for the Ig variable region (Mc-
Heyzer-Williams et al 1991, Honjo et al 2002). The GC environment is highly competitive 
and selective and therefore GC B cells that acquire mutations leading to lower affinity or 
loss of specificity rapidly undergo cell death due to engagement of the pro-apoptotic 
receptor Fas (Hao et al 2008). Higher affinity B cells which can take up more antigen for 
presentation to T follicular helper cells, get T cell help via CD40-CD40L interactions and 
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therefore survive the GC selection process. After undergoing multiple rounds of selection 
and clonal expansion, the GC B cells eventually exit the GC as plasma cells or memory B 
cells (Kawabe et al 1994, Batista and Harwood 2009, Mc-Heyzer Williams et al 2012, 
Silva and Klein 2015). 
 
Recent studies have shown that the first cells to exit the GC are the low to medium affinity 
memory B cells that remain in circulation. These are then followed by high affinity long 
lived memory plasma cells that probably occupy a survival niche in the bone marrow 
(Weisel et al 2016). Besides IgG- and IgA-switched memory B cells, another population of 
isotype-switched B cells that arise from the GC and whose molecular features are the 
least understood, are the IgE memory B cells. 
 
2.6 The biological role of IgE  
 
IgE is the least abundant Ig isotype in the blood with a serum half-life of about 2 days in 
humans and about 5-12 hours in mice (Achatz et al 2010). It is a critical mediator of 
immediate hypersensitivity reactions and has hence gained a lot of limelight due to its 
clinical significance. IgE can be mainly found in the skin, alveoli and intestine where it 
coats the surface of mast cells and basophils via its interaction with FcRs expressed on 
these cells, also in the absence of residual antigen. The entry of antigens or allergens (for 
example pollen) into the body, and subsequent binding to this pre-formed IgE-FcR 
complex induces very rapid mast cell degranulation due to which allergies can present 
themselves within minutes. The response is mediated by FcR-induced intracellular 
signaling pathways which culminate in secretion of granules containing histamine and/or 
secretion of cytokines and lipid mediators by these cells. The net result is vasodilation, 
bronchoconstriction and chemotaxis of leukocytes to the site, all contributing to the severe 
symptoms exhibited by allergy patients (Turner and Kinet 1999, Gould and Sutton 2008, 
Holgate and Polosa 2008, Wu and Shereens 2014). Treatment with anti-histamines and 
cortisol can provide temporary relief from these symptoms. However, the fact that IgE-
FcR complexes persist for long periods of time and sensitize mast cells to rapidly 
respond to antigens, demonstrates the need to treat allergies by targeting IgE. This has 
led to the clinical testing of monoclonal antibodies like Omalizumab, which can block IgE-
FcR interactions by neutralizing soluble IgE as therapy for allergies (Schulman 2001). 
 
Besides playing a major role in allergic diseases, IgE also has a biological role, which 
does not attract as much attention. The physiological role of IgE is to clear extracellular 
pathogens like helminths, which cannot be phagocytosed due to their large size. This 
function is mediated by a complex consisting of helminth-bound IgE interacting with FcRs 
on the surface of mast cells, basophils and eosinophils. The direct mediators of pathogen 
killing in this case are the eosinophils which secrete granules containing cytotoxic 
proteins. Mast cells and basophils also contribute to pathogen clearance by facilitating 
activation and attraction of leukocytes to the site of infection (Gurish et al 2004, Mitre et al 
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2006, Allen and Maizels 2011). Thus, the biologically relevant role of IgE in the immune 
system is to facilitate elimination of pathogens like helminths. Despite the clinical and 
biological significance of IgE, it is not completely clear which B cell compartment 
maintains IgE memory. 
 
2.7 Is there a true IgE memory compartment? 
 
Until recently, it was debated whether true mIgE-expressing memory B cells even exist in 
vivo. This is mainly due to the scarce nature of mIgE-expressing cells and that accurate 
staining for mIgE on B cells is blurred by FcR-bound IgE on B cells and other immune 
cells. These issues were overcome by the use of mouse models where the  heavy chain 
locus was specifically targeted at the exons encoding the membrane isoform to express 
fluorescent proteins that would serve as definitive reporters for mIgE-positive B cells 
(Yang et al 2012, He et al 2013, Talay et al 2014). Collectively, these studies confirmed 
the presence of a transient pool of mIgE-positive GC B cells and a larger pool of mIgE-
positive plasma cells in vivo. In addition, infection models using the model helminth 
Nippostrongylus brasiliensis confirmed the presence of antigen-specific IgE memory 
responses, as marked by high IgE antibody titers upon re-challenge with the helminth 
(Talay et al 2014).  
 
Unlike the mIgG-positive population, mIgE-positive GC B cells were shown to be short 
lived since they would either undergo rapid differentiation into plasma cells (Yang et al 
2012) or were susceptible to apoptosis (He et al 2013). There has been a report of 
preferential expansion of mIgE-positive cells in the absence of Fas expression on GC B 
cells, indicating higher apoptosis susceptibility of these cells in a GC (Butt et al 2015). Due 
to the short life of mIgE memory B cells, the current belief in the field is that IgE memory 
resides in the mIgG1-positive B cell population and that antigen recognition induces rapid 
differentiation of these cells into IgE-secreting plasma cells (He et al 2013, Yang et al 
2012).  In fact, analysis of the switch region in the  locus shows remnants of the 1 switch 
region, indicating a sequential isotype switch from 1 to  heavy chain. This feature has 
now been validated for human B cells as well. Nevertheless, direct isotype switching to 
IgE has also been confirmed for both species, providing evidence towards the existence 
of an IgE memory fraction (He et al 2013, Ramadani et al 2016, Berkowska et al 2014).  
 
In summary, an IgE memory compartment exists. However, the molecular basis behind 
IgE memory B cell activation and differentiation remains largely unclear since most work 
on memory B cell biology has focused on mIgG-positive memory B cells. Studies on IgG 
memory B cells clarified that the unique property of rapid activation and differentiation of 
memory B cells can be attributed to both BCR-extrinsic cellular factors as well as mIgG-
intrinsic signaling features, as discussed in the next sections (Wienands and Engels 
2015). 
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2.8 How B cells remember – cellular features of memory B cell responses 
 
One of the hallmarks of the humoral immune system is a robust memory response to 
recurring infections that is generally marked by elevated serum IgG titers. This 
phenomenon is brought about by the circulating pool of memory B cells that undergo rapid 
expansion and differentiation within 2-3 days of pathogen re-encounter (Dixon et al 1954, 
Yefenof et al 1986, Tangye et al 2003, Hebeis et al 2004). The bone marrow resident pool 
of long-lived memory plasma cells also contributes by constantly secreting protective 
antibodies and thus helping to maintain long term immunity (Radbruch et al 2006). The 
features that underlie the speed and efficiency of memory responses previously remained 
largely unclear. This is due to paucity of antigen-specific memory B cells and 
heterogeneity in the memory B cell compartment, which makes identification and isolation 
of these cells cumbersome. More recently, the use of new sophisticated mouse models 
have led to a significant improvement in our understanding of how memory B cells 
function. 
 
Gene expression analysis in memory B cells has revealed that they express high levels of 
factors that promote survival, proliferation and T cell co-stimulation, all of which contribute 
to prompt re-activation of these cells (Tangye et al 2003, Good and Tangye 2007, Klein et 
al 2003). Memory B cells were also found to express lower levels of the differentiation 
inhibitory protein Bcl6 as compared to their naïve counterparts (Bhattacharya et al 2009, 
Tomayko et al 2008). Additionally, mIgG1-expressing B cells that have undergone 
previous exposure to the antigen can mount a quantitatively superior antibody response 
due to antigen-dependent altered gene expression patterns (Kometani et al 2013). Higher 
expression of the cell surface molecules CD80 and Programmed death ligand 2, which 
are possibly involved in increasing T cell co-stimulatory signals, was also indicated to be 
associated with increased differentiation of memory B cells into plasma cells (Zuccarino et 
al 2014). Finally, two independent studies collectively demonstrated that higher affinity 
IgG memory B cells dominate the memory response and preferentially differentiate into 
plasma cells whereas the lower affinity IgM memory B cells re-enter the GC reaction 
(Dogan et al 2009, Pape et al 2011). Thus, a combination of aspects like BCR isotype, 
affinity and protein expression profile equip a memory B cell with the ability to effectively 
clear the antigen and protect us from infections. The role of the BCR isotype in modulating 
memory B cell responses was further pinned down to unique signaling mechanisms 
employed by mIgG-positive memory B cells as discussed next. 
 
2.9 BCR signal amplification via the immunoglobulin tail tyrosine (ITT) motif 
 
In contrast to the short cytoplasmic tail of mIgM that contains only three amino acids, 
mIgG and mIgE contain a longer cytoplasmic tail consisting of 28 amino acid residues. 
The amino acid sequences of these cytoplasmic tails show a high degree of conservation 
between different species, in particular for mIgG. Pioneering work in the 1990s indicated 
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that the mIgG1 and mIgE tails are important for robust memory antibody responses of 
these Ig isotypes. Mice lacking the cytoplasmic tail segment of either mIgG1 or mIgE were 
shown to produce reduced IgG1 or IgE antibody responses, respectively (Kaisho et al 
1997, Achatz et al 1997). Moreover, mice genetically engineered to express mIgM-BCRs 
containing the mIgG1 cytoplasmic tail segment displayed robust IgG-like IgM antibody 
responses (Martin and Goodnow 2002).  
  
Recently, it was demonstrated by our group that the longer cytoplasmic tails of mIgG and 
mIgE contain a conserved signaling motif now called the immunoglobulin tail tyrosine 
(ITT) motif (Engels et al 2009). ITT-like motifs can also be found in certain co-receptors in 
NK cells, T cells and other myeloid cells (Engels and Wienands 2011). The motif contains 
a highly conserved YxN amino acid core sequence (x being any amino acid), which forms 
a perfect consensus binding site for the SH2 domain-containing adaptor protein Grb2. 
Upon mIgG-BCR stimulation, the ITT motif is phosphorylated by Syk, which leads to 
recruitment of Grb2 via its SH2 domain. Through its N-terminal SH3 domain, Grb2 recruits 
Btk to the mIgG tail thereby enhancing the activation of the Ca2+ initiation complex (see 
Fig. 2). This leads to increased Ca2+ flux in the cells and lowers the activation threshold for 
these cells (Engels et al 2009, Engels et al 2014).  
 
The in vivo significance of the ITT motif was analyzed using a mouse model containing a 
single amino acid substitution of tyrosine to phenylalanine in the ITT motif at the 1m 
locus (referred to as mIgG1-YF mutant mice) (Lutz et al 2015). The formation of the 
mIgG1-positive memory compartment was completely normal in these mice. However, 
upon immunization, the mIgG1-YF mice displayed severely reduced serum IgG1 levels 
along with reduced numbers of IgG1-secreting plasma cells (see Fig. 2). Transfer of wild-
type mIgG1 B cells into Rag1-/- mice (which lack T and B cells) led to enhanced IgG1 
production when compared to transfer of mIgG1 B cells from the mIgG1-YF mice. Thus, 
the ITT promotes the production of IgG1 antibodies in a T cell-independent manner. 
Signaling via the mIgG-ITT is solely dependent on Grb2 since adoptive transfer of mIgG-
expressing cells into Rag1-/- mice enhanced IgG production in a Grb2 dependent manner 
(Engels et al 2014) which is in congruence to a previous study that found reduced IgG 
responses in Grb2 deficient mice (Ackermann et al 2011). Lastly, the ITT also promotes 
the long term survival of mIgG1 cells as more antigen-specific mIgG1 memory B cells 
were detected 250 days after immunization. Therefore, the ITT motif promotes survival 
and revival of memory B cells, thereby acting as a molecular determinant of memory 
responses.  
 





Figure 2: BCR signal amplification by the mIgG-ITT motif alters IgG memory responses. 
(A) The short cytoplasmic tail of the mIgM is depicted. mIgM-BCR activation leads to ITAM signaling induced 
Ca
2+
 flux and ERK activation as described in Fig. 1. (B) The longer cytoplasmic tail of mIgG (mouse 2am 
sequence shown here) is depicted with the ITT motif highlighted in blue. mIgG-BCR engagement activates the 
canonical ITAM signaling pathways as described for mIgM-BCRs. In addition, mIgG-ITT phosphorylation leads 
to recruitment of the Grb2-Btk module to the mIgG tail thereby augmenting Ca
2+
 flux via mIgG-BCRs. (C) An 
illustrative time course of antibody responses upon primary (1
o
) and secondary (2
o
) infection with a pathogen. 
Primary responses are marked by naïve B cells that mount low to moderate serum IgM titers (in red), whereas 
secondary responses involve memory B cell-mediated high serum IgG titers (in blue). Mice with a wild-type 
mIgG1-BCR mount normal IgG1 responses whereas mIgG1-ITT mutant mice (mIgG1-YF mice) mount IgG1 
responses which are more reminiscent of IgM responses (in black). Dashed lines represent indirect effects 
and solid lines represent direct effects. Purple-kinases, green-adaptor proteins and Ig/Ig heterodimer, red-
mIgM and Ca
2+ 





2.10 Additional molecular features of the mIgG tail 
 
Besides the ITT, a so called SSVV (single letters for amino acids) motif was identified in 
the cytoplasmic tail of mIgG and shown to enhance IgG-BCR clustering via recruitment of 
a protein called SAP97 (Liu et al 2012). However, a mutant SSVV motif in the mIgG tail 
does not have any effect on Ca2+ signaling in B cells (Engels et al 2014). Moreover, since 
immunodeficient mice that were reconstituted with SAP97-deficient B and T cells did not 
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display any defects in IgG responses, the motif probably does not play a role in enhancing 
memory responses in vivo (Hawkins et al 2013). More recent studies into the role of the 
mIgG tail indicated that positively charged amino acid residues in its cytoplasmic tail 
anchor it to the plasma membrane via interactions with acidic phospholipids, the functional 
role for which remains however unknown (Chen et al 2015). Finally, the BCR is also 
known to sense physical properties like the stiffness of the antigen to initiate B cell 
activation (Wan et al 2013). In connection to this, it was shown that mIgG-BCRs possess 
a lower threshold for mechanical force-induced activation as compared to mIgM-BCRs, 
which may also contribute to their improved activation capabilities (Wan et al 2015). 
 
2.11 How does the ITT influence mIgE-BCR signaling? 
 
Mice that cannot express mIgE due to targeted deletion of the transmembrane region 
have almost undetectable levels of serum IgE upon helminth infection (Achatz et al 1997). 
This indicates that even though transient, a mIgE-BCR-positive phase exists and is 
absolutely required for IgE production. Hence, mIgE-BCR signaling probably plays a 
crucial role in the activation of IgE memory B cells and regulation of serum IgE responses. 
The mIgE cytoplasmic tail from both mice and humans contain the ITT motif, which may 
contribute to mIgE-BCR signaling. There is only one mIgE isoform in mice, whereas 
human mIgE exists in two membrane isoforms referred to as long and short (Zhang et al 
1992, Batista et al 1995, Batista et al 1996). The long isoform contains 52 additional 
amino acid residues N-terminal of the transmembrane region, termed the extracellular 
membrane-proximal domain (EMPD). Both isoforms are expressed on human B cells 
(Zhang et al 1992, Batista et al 1995) and in fact a monoclonal antibody against the 
EMPD called Quilizumab is currently under trial in the clinics to treat allergies (Chen et al 
2002, Gauvreau et al 2014). Since both isoforms of human mIgE have an identical 
cytoplasmic tail, they both contain an ITT motif which may contribute to IgE memory 
responses. IgE-mediated allergic responses are a major health concern and insights into 
the molecular signaling mechanisms of mIgE-BCRs could prove to be relevant to finding 
ways of preventing the activation/expansion of IgE memory B cells. Therefore, to better 
understand the biology behind IgE memory responses, this work has focused on the 
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2.12 Scope of the thesis 
 
The biology of mIgE-expressing B cells remains elusive despite its relevance in allergic 
diseases. The mIgE cytoplasmic tail contains the evolutionarily conserved ITT motif. The 
ITT was previously shown to enhance BCR signaling and IgG responses in vivo in the 
context of mIgG-BCRs (Lutz et al 2015, Engels et al 2014, Engels et al 2009). However, 
the molecular details of mIgE-ITT signaling remained unknown. The scarcity of mIgE-
positive cells makes it very difficult to analyze mIgE-BCR signaling in vivo using mouse 
models or ex vivo using isolated human blood B cells. Therefore, I utilized human B cell 
lines to express the short isoform of human IgE and analyze mIgE-BCR induced signaling 
pathways. In this study, I addressed the following questions regarding the functional 
properties of mIgE-BCRs -  
 
 What is the functional role of the mIgE-ITT in BCR proximal signaling processes? 
 
 Which signaling proteins function downstream of the mIgE-ITT? 
 
 Can the mIgE-ITT mediate signal transduction independently of the Ig-Ig 
heterodimer? 
 





3.1 The ITT increases the sensitivity of mIgE-BCRs by utilizing the adaptor 
proteins Grb2 and Grap.  
 
The ITT motif is highly conserved at the amino acid level in higher vertebrate species 
where it is present in the cytoplasmic tail of mIgG, mIgE and mIgY (Fig. 3A). In order to 
analyze the functional properties of the ITT motif, I introduced the mIg heavy chains of 
different isotypes into the human B cell line DG75 by retroviral transduction. The 
expressed mIg heavy chains pair with the endogenous kappa light chain of DG75 cells 
and the Ig-Ig heterodimer to form a fully functional BCR on the cell surface. I used the 
mouse 2am (a mIgG subclass), human ms (short isoform of mIgE) and a 2am-m 
chimera where the mouse 2am cytoplasmic tail was replaced with that of m (mIgY) from 
the lizard Anolis carolinensis. The BCRs were expressed in either WT or tyrosine to 
alanine (YA) ITT-mutant configurations to analyze the effect of the ITT on BCR signaling 
(Fig. 3B). DG75 cells also express an endogenous mIgM-BCR, whose signaling 
properties should be identical irrespective of which exogenous BCR is expressed by the 
transfected cells, and therefore this served as an internal control. 
 
Stimulation of the WT ITT-containing BCRs considerably enhanced Ca2+ flux in cells as 
compared to the ITT-YA BCRs in all isotypes analyzed (Fig. 3C-E). Similar levels of 
signaling by the endogenous mIgM-BCRs demonstrated that the signaling capabilities of 
the cells were preserved in case of all transfectants (Fig. 3F-H). Furthermore, surface 
expression of the BCRs was analyzed and demonstrated that the ITT-YA mutant BCRs 
were expressed at the same or even slightly higher levels than the WT BCRs (Fig. 3I-K). 
This eliminated the possibility of expression-related differences in Ca2+ signaling between 
WT and ITT-YA BCRs. These results demonstrate that the ITT is the primary signal 
amplification device present in memory-type BCRs of higher vertebrate species (result 
published in Engels et al 2014). 
 
The ITT-YA substitution reduced the Ca2+ signaling of mIgE-BCRs to levels similar to 
those seen on stimulation of mIgM-BCRs (Fig. 3). This indicated that the ITT might be the 
key signal amplification device of the mIgE cytoplasmic tail. To test this notion, I 
generated a variant of the mIgE molecule which had a short cytoplasmic tail consisting of 
only four amino acids, namely MVQR (single letter amino acid code, referred to as tailless 
from here on), that were retained for membrane-anchoring of the molecule (Fig. 4A). The 
tailless mIgE-BCR displayed lower expression as compared to the WT and ITT-YA mIgE-
BCRs in DG75 B cells (Fig. 4B). However, upon mIgE-BCR stimulation, the Ca2+ kinetics 
were similar for the ITT-YA and the tailless mIgE-BCRs (Fig. 4C). The endogenous mIgM-
BCR-induced signaling was similar for all transfectants (Fig. 4D).  




Figure 3: The ITT is the primary signal amplification module in memory type-BCRs.  
(A) Amino acid sequence alignment of the cytoplasmic tail segments of mIgG (m), mIgE(m) and mIgY(m) 
from various higher vertebrate species. The conserved ITT motif is highlighted in blue. (B) Schematic 
illustration of the experimental setup used to analyze memory type-BCRs. The mIgG, mIgE and mIgG/Y BCRs 
were expressed using retroviral transduction in wild-type DG75 human B cells in WT or inactivated ITT-YA 
configuration. The Ca
2+
 mobilization kinetics of the mIgG-ITT (C) and mIgY-ITT (E) upon stimulation with 10 
g/ml anti-mouse-IgG F(ab)’2 fragments or the mIgE-ITT upon stimulation with 10 g/ml anti-human-IgE 
antibody (D). Stimulation with 20 g/ml anti-human-IgM F(ab)’2 fragments as control for cells expressing 
mIgG- (F), mIgE- (G) and mIgG/Y-BCRs (H). Surface expression of WT and ITT-YA mutant mIgG- (I), mIgE- 
(J) and mIgG/Y-BCRs (K). Data are representative of at least two independent experiments. 





Figure 4: The ITT is the sole signaling motif in the mIgE cytoplasmic tail. 
(A) Schematic representation of wild-type DG75 cells expressing the WT, ITT-YA mutant or tailless mIgE-
BCRs. The tailless mIgE has a short cytoplasmic tail with only four N-terminal amino acids namely, MVQR. 
(B) Surface expression of the mIgE-BCR variants. Ca
2+
 mobilization kinetics of the cells upon stimulation with 
10 g/ml anti-human-IgE antibody (C) or 20 g/ml anti-human-IgM F(ab)’2 fragments as control (D). Data are 
representative of three independent experiments. 
 
 
This experiment gave some relevant insights into mIgE-BCR signaling. First, the mIgE 
molecule lacking the cytoplasmic tail is not as efficiently transported to the cell surface as 
compared to mIgE with an intact cytoplasmic tail. Secondly, the ITT turned out to be the 
only signal amplification device in the mIgE cytoplasmic tail since the tailless variant has a 
signaling capacity similar to the ITT-YA mIgE-BCR.  
 
Next, I turned my focus on further analysis of the human mIgE-BCR and its signaling 
mechanisms which were not well understood. I first looked at how signal amplification by 
the ITT affects the activation threshold of mIgE-expressing B cells. Upon titrating the 
amount of stimulating antibody, one can see that BCR signaling via the mIgE-ITT required 
approximately 5 fold less antigen (stimulating antibody in this case) than the ITT-YA 
mutant to induce comparable Ca2+ mobilization kinetics (Fig. 5A, compare green curve for 
WT with purple curve for YA mutant). Again, endogenous mIgM-BCR-induced Ca2+ flux is 
the same for cells expressing the ITT variants (Fig. 5B). I also analyzed the effect of the 
ITT on the phosphorylation of the MAP kinase ERK, a protein that plays a critical role in 
the activation of B cells (Yasuda et al 2011). ERK phosphorylation was similar at high 
antigen concentrations, however, under sub-optimal stimulation conditions, the ITT-
containing mIgE-BCR more efficiently activated ERK than the YA-mutant counterpart (Fig. 
5C). Combined, these data show that the ITT lowers the activation threshold of signaling 
pathways downstream of the mIgE-BCR, thereby equipping mIgE-expressing B cells with 
the capability of being efficiently activated at low antigen concentrations. 
 





Figure 5: The ITT increases the sensitivity of mIgE-BCRs 
(A) DG75 B cells were used to measure Ca
2+
 mobilization kinetics of the WT and ITT-YA mutant mIgE-BCRs 
upon stimulation with the indicated concentrations of anti-human-IgE antibody. (B) mIgM-BCR induced Ca
2+
 
mobilization of the same cells using 20 g/ml anti-human-IgM F(ab)’2 fragments. (C) Cell lysates were 
prepared after stimulation of WT and ITT-YA mutant mIgE-BCRs with indicated concentrations of anti-human-
IgE antibody. ERK phosphorylation was analyzed by SDS-PAGE and immunoblotting with antibodies against 
phospho-ERK (p-ERK) or total ERK (pan-ERK). Relative levels of phospho-ERK to total ERK were quantified 
and are given at the bottom. Data are representative of two (A, B) or three (C) independent experiments. 
 
The next question that I addressed was to find which tyrosine kinase phosphorylates the 
ITT motif in mIgE. The ITAMs present in the Ig/Ig heterodimer are thought to be initially 
phosphorylated by Src family kinases such as Lyn (Rolli et al 2002), which leads to 
recruitment of Syk to doubly phosphorylated ITAMs (Johnsen et al 1995, Kurosaki et al 
1995). Syk can then activate downstream signaling molecules and also perhaps 
contribute to a certain degree to ITAM phosphorylation (Rolli et al 2002). To test which of 
the two BCR-associated kinases are required for ITT phosphorylation, I treated DG75 
cells expressing a WT mIgE-BCR with the Src kinase inhibitor PP1 or the Syk inhibitor 
Bay61-3606. Next, I stimulated the mIgE-BCR with a biotinylated anti-IgE antibody and 
used this antibody to purify mIgE molecules. I found that inhibition of Syk abrogated ITT 
phosphorylation (Fig. 6A). Lyn inhibition also inhibited ITT phosphorylation but this is 
probably due to lack of Syk recruitment to the BCR since Lyn functions upstream of Syk in 




Figure 6: The human mIgE-ITT is phosphorylated by the tyrosine kinase Syk. 
(A) DG75 cells expressing a WT mIgE-BCR were treated for 30 min with 30 M Src kinase inhibitor PP1 or 30 
M Syk kinase inhibitor Bay61-3606 or left untreated (-). The cells were then left unstimulated (0) or 
stimulated for 3 min (3) with 10 g/ml anti-human-IgE-Biotin antibody. ITT-YA mIgE-BCR-expressing cells 
were used as control. Cell lysates were prepared and the BCR complex was purified using streptavidin beads 
and analyzed by SDS-PAGE and immunoblotting. mIgE-ITT-phosphorylation was detected using the anti-p-
Tyr100 antibody. The blot was also probed with anti-Syk and anti-IgE antibodies. (B) Cell lysates from (A) 
were separately analyzed by SDS-PAGE and immunoblotting for phospho-SLP65 and total SLP65 was used 
as loading control. Data are representative of three independent experiments. 
 
the signaling cascade (Kurosaki et al 1995, Keshvara et al 1998). To confirm the 
efficiency of inhibitor activity, I analyzed SLP65 phosphorylation (a downstream target in 
the signaling cascade) in cell lysates and found that both inhibitors were functional (Fig. 
6B). 
 
Having established that the mIgE-ITT is phosphorylated by Syk, the next step was to find 
which effector molecule is responsible for the ITT-mediated signal amplification of mIgE-
BCRs. The phospho-YxN core motif of the ITT is a perfect consensus binding site for the 
SH2 domain of the adaptor molecule Grb2 (schematically depicted in Fig. 7A). It has been 
previously published that Grb2 is the main effector molecule for signal amplification by the 
mIgG-ITT. This process is dependent on the N-terminal SH3 domain of Grb2, which 
recruits Btk to the mIgG-BCR signaling complex (Engels et al 2014). Hence, I used a 
derivative of DG75 cells made deficient for GRB2 by gene targeting (DG75 GRB2 KO) 
(cells generated by Dr. Johannes Lutz).  I expressed the mIgE-BCR variants in these cells 
to test if the mIgE-ITT also requires Grb2 for signal amplification. As control, I analyzed 
mIgG-BCR signaling in the same cellular background. As expected, the mIgG-ITT 
completely lost its signal amplification capabilities in GRB2 KO cells (Fig. 7B). Although, 
the relative degree of mIgE-ITT signal amplification was reduced in the GRB2 KO 
compared to wild-type DG75 cells, it was not completely eliminated (Fig. 7C). 




Figure 7: The human mIgE-ITT is partly functional even in the absence of the adaptor protein, Grb2. 
(A) Schematic illustration highlighting the core residues in the ITT motif which form a binding site for the SH2 
domain of Grb2. DG75 GRB2 KO cells were therefore used to analyze ITT function. Ca
2+
 flux in GRB2 KO 
cells expressing WT or ITT-YA mutant mIgG- or mIgE-BCRs, stimulated with 10 g/ml anti-mouse-IgG F(ab)’2 
fragments (B) or 10 g/ml anti-human-IgE antibody (C) respectively. Ca
2+
 flux following stimulation with 20 
g/ml anti-human-IgM F(ab)’2 fragments for cells expressing mIgG-BCRs (D) or mIgE-BCRs (E). Surface 
expression of the mIgG-BCR (F) and mIgE-BCR (G) variants. Data are representative of at least two 
independent experiments. 
 
This would imply that another protein can partially compensate for the loss of Grb2 in the 
context of the mIgE-ITT. Endogenous mIgM-BCR induced Ca2+ signaling (Fig. 7D,E) and 
relative surface expression of the ITT variants (Fig. 7F,G) were comparable in the mIgG- 
and mIgE-BCR-expressing cells. 
 
Since the core of the ITT motif contains a conserved asparagine (N) residue at the +2 
position relative to the phosphorylated tyrosine, I replaced this residue with an alanine, 
generating a mIgE-NA mutant (Fig. 8A). Upon expression of the WT, YA and NA mutant 
mIgE-BCRs in wild-type DG75 B cells (Fig. 8B), I observed that the NA mutant responds 
like the YA mutant in that ITT signal amplification is completely abolished (Fig. 8C). As 
always, endogenous mIgM-BCR signaling was similar for all transfectants (Fig. 8D). This 
shows that both the tyrosine and the asparagine residues in the ITT motif core are critical 
for binding of mIgE-ITT effector molecules.  




Figure 8: Signal amplification by human mIgE-BCRs depends on the asparagine residue in the ITT 
motif core. 
(A) Schematic illustration of the experimental setup used to analyze the mIgE-ITT motif core. Wild-type DG75 
cells were transfected with mIgE-BCRs containing a WT, ITT-YA mutant or ITT-NA (asparagine to alanine 
substitution) mutant. (B) Surface expression of the mIgE-BCR variants. Ca
2+
 mobilization kinetics of the cells 
upon stimulation with 10 g/ml anti-human-IgE antibody (C) or 20 g/ml anti-human-IgM F(ab)’2 fragments 
(D). Data are representative of three independent experiments. 
 
 
To obtain a more comprehensive view of mIgE-ITT interaction partners, I used a synthetic 
biotin-tagged phospho-peptide encompassing the ITT motif and the surrounding amino 
acids to affinity purify proteins that bind to the ITT in a phosphorylation dependent manner 
(Fig. 9A). The mIgE-ITT interaction partners purified from SILAC-labeled B cell lysates 
were identified via mass spectrometry (done in collaboration with the Proteomics Core 
Facility of University Medical Center Göttingen). A non-phosphorylated peptide was used 
as a negative control so that proteins that specifically bind to the phosphorylated mIgE-ITT 
alone are enriched (Fig. 9B). After applying a 2.0 fold enrichment ratio cut-off for proteins 
that fulfilled the significance conditions, 22 proteins were found to associate with the 
phosphorylated mIgE-ITT (Fig. 9C,D). It is important to note that these proteins include 
both direct and indirect interaction partners. Interestingly, the Grb2 related adaptor 
protein, Grap was purified along with the mIgE-ITT and was amongst the proteins that 
showed the highest enrichment (highlighted in red in Fig. 9D). Grap was previously 
identified as a direct interaction partner of the mIgG-ITT as well. However, it was 
demonstrated to be incapable of amplifying BCR signaling in the case of the mIgG-ITT, 
which was solely dependent on Grb2 (Engels et al 2014, Fig. 7B). Nevertheless, if one 
combines the knowledge that Grb2 and Grap share a high degree of homology 
(schematically represented in Fig. 10A) and that mIgE-ITT signal amplification depends on 
the YxN ITT core motif, Grap would make an ideal candidate as a second effector 
molecule of the mIgE-ITT.  





Figure 9: Mass spectrometric analysis of the phosphorylated mIgE-ITT interactome. 
(A) Amino acid sequence of the N-terminally biotinylated human mIgE phospho-ITT peptide used. (B) 
Experimental outline for affinity purification of phospho-ITT binding partners from DG75 cells. Lysates from 
cells labeled with heavy (H) amino acids Lysine D4 (Lys+4), Arginine 
13
C6 (Arg+6) were treated with the 
phospho-ITT peptide and lysates from cells labeled with light (L) amino acids Lysine (Lys+0) and Arginine 
(Arg+0) were treated with the non-phosphorylated ITT peptide and subsequently purified using streptavidin 
beads. (C) Scatter plot representing distribution of significantly enriched proteins by plotting normalized ratio 
of H/L vs. intensity. Proteins with a normalized H/L ratio of greater than 2.0 fold are highlighted in red with their 
gene names. (D) Proteins highlighted in (C) are represented in tabular format with values for normalized H/L 
ratio, number of peptides, gene name, protein ID and protein name. Grb2 and Grap are highlighted in red. The 
mass spectrometry analysis and preliminary data processing was done in collaboration with the Proteomics 
Core Facility of University Medicine Göttingen. Data are from one experiment. 





Figure 10: The mIgE-ITT binds to the closely related adaptor proteins Grb2 and Grap. 
(A) Illustration depicting the domain architecture of Grb2 and Grap. (B) Cell lysates from wild-type DG75 cells 
were used to purify binding partners using the biotinylated mIgE phospho-ITT peptide (sequence in Fig. 9A) 
and streptavidin beads. The non-phosphorylated peptide was used as negative control and the purified 
samples were analyzed by SDS-PAGE and immunoblotting by probing for Grb2 and Grap. (C) DG75 cells 
expressing a WT mIgE-BCR were stimulated for 3 min with 10 g/ml anti-human-IgE antibody and cell lysates 
were prepared. The lysates were mixed with 15 g GST-tagged functional Grb2 and Grap SH2 domains (WT), 
SH2 domain mutants (R86L for Grb2 and R86K for Grap) or GST only, along with glutathione beads to purify 
interaction partners. Binding partners were analyzed by SDS-PAGE and immunoblotting. The phosphorylated 
mIgE-ITT was detected using the p-Tyr antibody.  The blot was also probed with anti-IgE and anti-GST 
antibodies. Data are representative of three independent experiments. 
 
 
In order to validate the mass spectrometry results, I biochemically tested for binding of 
Grap to the mIgE-ITT motif by two complementary approaches. First, I used the same 
synthetic peptide as described above to purify binding partners from cell lysates and 
confirmed the interaction with Grb2 and Grap by immunoblotting (Fig. 10B). Second, I 
used the SH2 domains of Grb2 and Grap as GST fusion proteins to purify the 
phosphorylated mIgE-BCR. Inactivated variants of the SH2 domains (R86L and R86K 
respectively) and GST served as negative controls. I could specifically detect the 
phosphorylated m heavy chain in the purified fraction obtained from the WT SH2 
domains of Grb2 and Grap (Fig. 10C). Thus, both Grb2 and Grap can directly bind to the 
phosphorylated mIgE-ITT via their SH2 domains. 
 





Figure 11: mIgE-ITT-mediated signal amplification is lost in the absence of Grb2 and Grap. 
DG75 GRB2/GRAP dKO cells that were transfected with WT and ITT-YA mIgE-BCRs. (A) Ca
2+
 mobilization 
kinetics of the cells upon stimulation with 10 g/ml anti-human-IgE antibody. (B) The endogenous mIgM-BCR 
induced Ca
2+
 flux of the cells using 20 g/ml anti-human-IgM F(ab)’2 fragments. (C) Surface expression of the 
mIgE-BCR variants in these cells. Data are representative of four independent experiments. 
 
To test the functional significance of Grap binding to the mIgE-ITT, I used GRB2/GRAP 
double-deficient DG75 cells (referred to as GRB2/GRAP dKO) (provided by Caren 
Bartsch) and expressed the WT and ITT-YA mIgE-BCRs in these cells (Fig. 11C). Indeed, 
ITT-mediated signal amplification was completely abrogated in the absence of both the 
adaptor molecules (Fig. 11A). mIgM-BCR signaling was similar for cells with either ITT 
variant (Fig. 11B). Thus, unlike the mIgG-ITT, the mIgE-ITT utilizes both Grb2 and Grap 
for BCR-mediated signal amplification in human B cells. 
 
In order to eliminate the possibility of clonal selection-induced side effects causing the ITT 
phenotype in the DG75 GRB2/GRAP dKO, I reconstituted expression of the adaptor 
proteins in these cells. Retroviral constructs encoding GRB2-IRES-GFP and GRAP-IRES-
RFP were used for the reconstitution (schematic depiction in Fig. 12A). Since the adaptor 
proteins are quite small themselves (about 25kDa), the fluorescent markers were not 
directly coupled to the proteins but expressed separately using an IRES site. The 
fluorescent markers enable selection of a pure positive population of cells via cell sorting. 
The GRB2/GRAP dKO cells expressing WT or ITT-YA mIgE-BCRs expressed similar 
amounts of GFP and or RFP post-sorting (Fig. 12B and C respectively). To directly test 
the expression of Grb2 and Grap in the sorted cells, I performed immunoblotting and 
confirmed that the adaptor proteins were expressed at comparable levels (Fig. 12D). Next, 
I examined the Ca2+ signaling properties of the reconstituted cells and used DG75 
GRB2/GRAP dKO and wild-type cells as controls. Again, the WT mIgE-BCR showed 
enhanced Ca2+ mobilization as compared to the ITT-YA mutant in wild-type cells (Fig. 
13A) and lost this capability in GRB2/GRAP dKO cells (Fig. 13B). Reconstitution with 
Grb2 (Fig. 13C), Grap (Fig. 13D) or both Grb2+Grap (Fig. 13E), all restored ITT mediated 
signal amplification in the GRB2/GRAP dKO background. There is also a certain degree 
of co-operativity in the mode of action of Grb2 and Grap, since the cells reconstituted with 
both adaptors showed higher signal amplification than the individually reconstituted cells. 
mIgM-BCR induced signaling was the same for cells expressing either mIgE-BCR variant, 
confirming equivalent internal signaling capabilities (Fig. 13F-J). 




Figure 12: Reconstitution of the DG75 GRB2/GRAP dKO with the adaptor proteins Grb2 and Grap. 
(A)  Schematic illustration of the retroviral expression vectors used for reconstitution of the DG75 
GRB2/GRAP dKO cells (dKO) with either GRB2-IRES-GFP or GRAP-IRES-RFP or both. Flow cytometric 
analysis of dKO cells expressing either WT (B) or ITT-YA (C) mIgE-BCRs that were sorted for GFP-positive 
(dKO+Grb2), RFP-positive (dKO+Grap) or GFP/RFP double-positive cells (dKO+Grb2+Grap). Cell lysates 
from the sorted cells were analyzed by SDS-PAGE and immunoblotting for expression of Grb2 and Grap (D). 
-actin levels were analyzed to confirm equal loading. Data are representative of three (B,C) or one (D) 
independent experiments. 
 
Intriguingly, analysis of the signal strength of the mIgM-BCR in GRB2/GRAP dKO cells, 
showed reduction in Ca2+ mobilization compared to wild-type DG75 cells (compare Fig. 
13F and G). This phenotype could also be restored by reconstitution with either or both 
adaptor proteins (Fig. 13H-J). Lastly, the surface expression of the WT and ITT-YA mIgE-
BCRs was comparable in all cells analyzed (Fig. 13K-O). Thus, both Grb2 and Grap not 
only amplify signaling at the mIgE-BCR via the ITT motif, but also contribute to canonical 
mIgM-BCR signaling, which is initiated exclusively via the ITAM motifs in Ig-Ig.  





Figure 13: Both Grb2 and Grap contribute to mIgE-ITT-mediated signal amplification. 
Ca
2+
 mobilization kinetics of DG75 cells expressing WT or ITT-YA mutant mIgE-BCR following stimulation with 
10 g/ml anti-human-IgE antibody (A-E) or 20 g/ml anti-human-IgM F(ab)’2 fragments (F-J) in the following 
cellular backgrounds: wild-type (A,F), GRB2/GRAP dKO (B,G), GRB2/GRAP dKO reconstituted with Grb2 
(C,H), GRB2/GRAP dKO reconstituted with Grap (D,I), GRB2/GRAP dKO reconstituted with Grb2+Grap (E,J) 
respectively. Surface mIgE expression of the ITT variants in DG75 wild-type (K), GRB2/GRAP dKO (L), 
GRB2/GRAP dKO reconstituted with Grb2 (M), GRB2/GRAP dKO reconstituted with Grap (N), GRB2/GRAP 
dKO reconstituted with Grb2+Grap (O). Data are representative of three independent experiments. 




Figure 14: mIgE- and mIgM-BCR induced ERK activation is dependent on Grb2 and Grap. 
(A) Cell lysates were prepared from wild-type and GRB2/GRAP dKO DG75 cells following stimulation with the 
indicated concentrations of anti-human-IgE antibody for 5 min. ERK phosphorylation was analyzed using 
SDS-PAGE and immunoblotting with antibodies against phospho-ERK (p-ERK) and total ERK (pan-ERK). 
Relative levels of phospho-ERK were quantified and are indicated below. (B and C) Wild-type DG75 cells, 
GRB2/GRAP dKO cells and GRB2/GRAP dKO cells reconstituted with both Grb2 and Grap, and expressing a 
WT mIgE-BCR were stimulated with 10 g/ml anti-human-IgE antibody (B) or 20 g/ml anti-human-IgM F(ab)’2 
fragments (C). The cell lysates were then analyzed by SDS-PAGE and immunoblotting for ERK activation by 
detecting phosphorylated ERK (p-ERK) and total ERK (pan-ERK). Relative levels of phosphorylated ERK 
were quantified and are given below each panel. Data are representative of three independent experiments. 
 
As an alternative signaling readout, I tested mIgE-BCR-induced ERK phosphorylation in 
the GRB2/GRAP dKO cells at various concentrations of stimulating antibody. Compared 
to wild-type cells, ERK phosphorylation is strongly diminished in the absence of Grb2 and 
Grap (Fig. 14A). This phenotype may be attributed to the interaction of Grb2 and Grap 
with the GEF, Son of sevenless (Sos). Sos is known to induce ERK activation via the Ras-
MAPK pathway following mIgM-BCR stimulation (Kumar et al 1995). mIgE-BCR-mediated 
ERK phosphorylation is indeed restored upon reconstitution of the GRB2/GRAP dKO cells 
with both Grb2 and Grap (Fig. 14B).  As control, I also tested for mIgM-BCR-induced ERK 
phosphorylation in the same cells and confirmed the need for Grb2 and Grap for efficient 
ERK activation by this BCR isotype (Fig. 14C).  
 
Combining all these data, I discovered that upon activation of the mIgE-BCR, the ITT is 
phosphorylated by Syk leading to binding of Grb2 and/or Grap to the phosphorylated ITT. 
This leads to enhanced Ca2+ mobilization and efficient ERK phosphorylation via ITT-
containing mIgE-BCRs. Furthermore, an unexpected finding was the role of Grb2 and 
Grap in positively regulating mIgM-BCR induced Ca2+ signaling as well. Thus, Grb2 and 
Grap, positively regulate mIgE- and mIgM-BCR induced signaling processes in human B 
cells.  
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3.2 Deficiency of Grb2 and Grap prevents optimal activation of the canonical 
ITAM signaling pathway.  
 
The reduced mIgM-BCR-induced Ca2+ flux in the absence of Grb2 and Grap was a 
surprising finding since these proteins have never been implied to play a role in positively 
regulating the early events of mIgM-BCR activation. Therefore, I compared the Ca2+ 
mobilization kinetics of the mIgE-BCR and the mIgM-BCR in wild-type, GRB2 KO and 
GRB2/GRAP dKO cells. The effect of the absence of the adaptor proteins seems to be 
more profound on mIgE-induced signaling, probably due to the combined impact on ITAM 
and ITT signaling (Fig. 15A). The reduction on mIgM-BCR signaling is comparatively 
moderate but still apparent (Fig. 15B). The diminished BCR-induced signaling was not 
due to reduced BCR expression, which was comparable in all cellular backgrounds (mIgE 
expression in Fig. 15C and data not shown). 
 
Given that BCR-induced Ca2+ mobilization is controlled by a set of signaling proteins, 
collectively termed the Ca2+ initiation complex, I decided to analyze how Grb2 and Grap 
affect this complex. The tyrosine kinase Syk, the adaptor protein SLP65 and the 
phospholipase PLC2 were examined. To test their activation, I used cell lysates from 
wild-type and GRB2/GRAP dKO DG75 cells stimulated via the mIgE- or mIgM-BCR. 
Analysis of PLC2 phosphorylation following affinity purification with an anti-PLC2 
antibody revealed that PLC2 activation was markedly reduced in the absence of Grb2 
and Grap (Fig. 15D). Again the effect was more pronounced for the mIgE-BCR than the 
mIgM-BCR. I also used the same lysates and tested for phosphorylation of SLP65 (Fig. 
15E upper panel) and Syk (Fig. 15E lower panel). Both of these proteins also exhibited 
reduced activation in the absence of Grb2 and Grap. Thus, Grb2 and Grap somehow act 
upstream in the BCR signaling cascade by promoting efficient phosphorylation and 
activation of Syk, SLP65 and PLC2, downstream of both mIgM- and particularly mIgE-
BCRs. 
 
Both Grb2 and Grap have a central SH2 domain that binds phospho-tyrosine residues 
within the YxN core motif which recruits the proteins to signaling complexes. The SH2 
domain of either protein is flanked by two SH3 domains that constitutively bind effector 
proteins that relay the signal further. To determine which domains are essential for the 
function of Grb2, I reconstituted GRB2/GRAP dKO cells with various mutant versions of 
full-length Grb2 using the IRES-GFP vector to enable sorting of GFP-positive cells 
following transfection. The wild-type Grb2 (WT) or inactivated variants of the N-terminal 
SH3 domain, central SH2 domain or C-terminal SH3 domain (W36K, R86K and W193K 
respectively) were used (Fig. 16A). Upon stimulation of both the mIgE-BCR and the 
mIgM-BCR, the SH2 domain mutant could not restore the signaling defect of GRB2/GRAP 
dKO cells (Fig. 16B,C blue curve). However, the role of the two SH3 domains of Grb2 
differs depending on the mIg isotype analyzed. The mIgE-BCR seems to utilize either of 
the two Grb2 SH3 domains since both, the W36K and W193K mutant could independently  





Figure 15: The absence of Grb2 and Grap reduces activation of the Ca
2+
 initiation complex proteins. 
Ca
2+
 flux of wild-type DG75 cells, GRB2 KO cells and GRB2/GRAP dKO cells expressing WT mIgE-BCRs 
upon stimulation with 10 g/ml anti-human-IgE antibody (A), or 20 g/ml anti-human-IgM F(ab)2 fragments 
(B). (C) Surface expression of the mIgE-BCR in the different DG75 cell variants. (D) Wild-type DG75 cells and 
GRB2/GRAP dKO cells expressing WT mIgE-BCRs were left unstimulated (0) or stimulated for the indicated 
times with 10 g/ml anti-human-IgE antibody or 20 g/ml anti-human-IgM F(ab)’2 fragments. Cell lysates were 
mixed with 2 g anti-PLC2 antibody and protein AG sepharose beads to purify PLC2.  The purified proteins 
were analyzed by SDS-PAGE and immunoblotting with anti-p-Tyr100 antibody to measure activation of 
PLC2. The anti-PLC2 antibody was used as loading control and the ratio of phospho-PLC2 was quantified 
and is indicated at the bottom. (E) Activation of SLP65 and Syk was analyzed by using the cell lysates from 
(D) and probing with anti-p-SLP65 (upper panel) and anti-p-Syk (lower panel) antibodies. The total SLP65 and 
total Syk antibodies were used to quantify the ratio of phospho-SLP65 and phospho-Syk and is indicated 
below each panel. Data are representative of three independent experiments. 
 
 
restore Ca2+ flux to wild-type levels (Fig. 16B). In contrast, the N-terminal SH3 domain is 
required for mIgM-BCR induced Ca2+ flux and the C-terminal SH3 domain is dispensable 
for that process (Fig. 16C). GFP expression was similar for all transfectants (Fig. 16D). 
Again, as an additional BCR signaling readout, I analyzed ERK phosphorylation in these 
cells (Fig. 16E). All three Grb2 domains are required for ERK activation as only the wild-
type Grb2 protein could restore mIgE-BCR-induced ERK phosphorylation in the 
GRB2/GRAP dKO background. 
 




Figure 16: The N- and C-terminal SH3 domains of Grb2 have different roles in mIgE- and mIgM-BCR 
signaling. 
(A) Schematic representation of the Grb2 variants used: Grb2 wild-type (WT), N-terminal SH3 domain mutant 
(W36K), SH2 domain mutant (R86K) and C-terminal SH3 domain mutant (W193K). (B-E) DG75 GRB2/GRAP 
dKO cells expressing the WT mIgE-BCR were reconstituted with Grb2 variants using the IRES-GFP vector 
and GFP-positive cells were sorted for further analysis. Wild-type (wt) and GRB2/GRAP dKO (dKO) cells 
expressing the WT mIgE-BCR served as controls. Ca
2+
 mobilization by the cells upon stimulation with 10 
g/ml anti-human-IgE antibody (B) or 20 g/ml anti-human-IgM F(ab)’2 fragments (C). (D) GFP expression in 
the reconstituted cells. (E) The same cells as above were stimulated with 10 g/ml anti-human-IgE antibody 
for 2 or 5 min or left unstimulated (0). Cell lysates were prepared and ERK phosphorylation was analyzed by 
SDS-PAGE and immunoblotting with antibodies against phospho-ERK (p-ERK) or total ERK (pan-ERK). 
Relative levels of phospho-ERK to total ERK were quantified and are indicated below. Data are representative 
of three independent experiments. 
 
Grb2 and Grap share about 60% homology in amino acid sequence. It is published that 
the Grb2 N-terminal SH3 domain binds the PLC2-activating kinase Btk, whereas the 
Grap N-terminal SH3 domain cannot (Engels et al 2014). Hence, there do exist 
differences in the functional capabilities of these closely related adaptor proteins. 
Accordingly, I also examined the functional properties of the Grap domains by 
reconstituting the GRB2/GRAP dKO cells with wild-type Grap (WT) or inactivated N-
terminal SH3 domain, SH2 domain or C-terminal SH3 domain variants (W36K, R86K and 
W195K respectively) (Fig. 17A). This time, the IRES-RFP vector was used to sort for 
RFP-positive transfectants. 




Figure 17: The N-terminal SH3 domain of Grap is required for optimal mIgE- and mIgM-BCR-mediated 
signaling 
(A) Schematic representation of the Grap variants used: Grap wild-type (WT), N-terminal SH3 domain mutant 
(W36K), SH2 domain mutant (R86K) and C-terminal SH3 domain mutant (W195K). (B-E) DG75 GRB2/GRAP 
dKO cells expressing the WT mIgE-BCR were reconstituted with Grap variants using the IRES-RFP vector 
and RFP-positive cells were sorted for further analysis. Wild-type (wt) and GRB2/GRAP dKO (dKO) cells 
expressing the WT mIgE-BCR served as controls. Ca
2+
 mobilization by the cells upon stimulation with 10 
g/ml anti-human-IgE antibody (B) or 20 g/ml anti-human-IgM F(ab)’2 fragments (C). (D) RFP expression in 
the reconstituted cells. (E) The same cells as above were stimulated with 10 g/ml anti-human-IgE antibody 
for 2 or 5 min or left unstimulated (0). Cell lysates were prepared and ERK phosphorylation was analyzed by 
SDS-PAGE and immunoblotting with antibodies against phospho-ERK (p-ERK) or total ERK (pan-ERK). 
Relative levels of phospho-ERK to total ERK were quantified and are indicated below. Data are representative 
of three independent experiments. 
 
Again the SH2 domain mutant could not restore the Ca2+ flux defect of GRB2/GRAP dKO 
cells (Fig. 17B,C blue curve). However, The N-terminal SH3 domain seems to be required 
by both mIgE- and mIgM-BCRs since the W36K mutant could not restore the Ca2+ 
signaling (Fig. 17B,C red curve). The C-terminal SH3 domain of Grap was found to be 
dispensable for signaling via the mIgM- and mIgE-BCR. RFP expression was similar for 
all variants (Fig. 17D). Lastly, ERK phosphorylation was again dependent on all three 
domains of Grap as only wild-type Grap restored phospho-ERK levels in the GRB2/GRAP 
dKO cells (Fig. 17E). 
 




Figure 18: Grb2 and Grap are recruited to the BCR and/or to co-stimulatory molecules upon BCR 
activation 
Wild-type DG75 cells were stimulated for 3 minutes with 20 g/ml anti-human-IgM F(ab)’2 fragments and cell 
lysates were prepared. The lysates were mixed with 15 g GST-tagged functional Grb2 and Grap SH2 
domains (WT) and SH2 domain mutants (R86L for Grb2 and R86K for Grap) or GST only, along with 
glutathione beads to purify interaction partners. Purified proteins were analyzed by SDS-PAGE and 
immunoblotting. Phosphorylated interaction partners of the Grb2/Grap SH2 domains were analyzed using the 
p-Tyr-100 antibody. The blot was also probed with anti-Ig and anti-GST antibodies. Data are representative 
of at least two independent experiments. 
 
 
Since both Grb2 and Grap require their SH2 domains for performing their function, I 
wanted to find the binding partner/s that could recruit these proteins to the active mIgM-
BCR signalosome. GST fusion proteins containing either the Grb2 or Grap SH2 domain 
were used in wild-type or inactive configuration (R86L and R86K respectively), along with 
GST as an additional negative control. The SH2 domains purified a number of tyrosine-
phosphorylated proteins from mIgM-BCR-stimulated DG75 B cells (Fig. 18 upper panel). I 
could identify Ig as a major interaction partner for the Grb2 SH2 domain, an interaction 
that was lacking in case of the Grap SH2 domain (Fig. 18 second panel). The 90 kDa 
phospho-band in the anti-phospho-tyrosine blot represents the co-stimulatory molecule 
CD19, which was bound by both Grb2 and Grap (identified in separate experiments). 
Although, I cannot rule out other routes of recruitment at this point, I could partially localize 
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Combining these data, I found that upon mIgM-BCR stimulation, a pool of the adaptor 
proteins is recruited to either Ig (Grb2) or CD19 (Grb2 and Grap) via their SH2 domains. 
The presence of Grb2 and Grap at the signalosome contributes to ITAM-induced Ca2+ 
mobilization via improved activation of the Ca2+ initiation complex proteins, Syk, SLP65 
and PLC2. The effector functions of the SH3 domains of the adaptors differ depending on 
the BCR isotype. mIgE-BCR induced Ca2+ flux uses either Grb2 SH3 domain whereas the 
N-terminal SH3 domain of Grap is critical for this process. On the other hand, mIgM-BCR 
induced Ca2+ flux selectively utilizes the N-terminal SH3 domains of Grb2 and Grap for 
optimal signaling. The exact mechanism behind the function of these domains remains to 
be determined. Another relevant observation was that optimal ERK phosphorylation 
requires all three domains of Grb2 and Grap to be functional. Since this is not the case for 
Ca2+ signaling, the activation of the two pathways by Grb2 and Grap is probably partially 
independent of each other.  
 
 
3.3 Human mIgE can function independently of the Ig/Ig heterodimer.  
 
Upon analysis of Ca2+ signaling in wild-type and GRB2/GRAP dKO DG75 cells, I found 
that the mIgE-BCR is more dependent on the Grb2-family adaptors as compared to the 
mIgM-BCR. The drop in Ca2+ mobilization in the GRB2/GRAP dKO cells is more 
significant for the mIgE-BCR even at optimal concentrations of stimulating antibody (Fig. 
19A, D). This may be partly explained by the employment of ITT and ITAM signaling by 
mIgE-BCRs, while mIgM-BCRs use only ITAM signaling. However, the absence of Grb2 
and Grap should completely abrogate ITT signaling and thus the WT mIgE-BCR should 
signal at similar levels as the mIgM-BCR via its ITAMs. Intriguingly, this was not the case. 
When I titrated down the stimulating antibody to sub-optimal concentrations of 2 g/ml 
(Fig. 19B, E) and 1 g/ml (Fig. 19C, F), I observed that the mIgE-BCR could not signal 
anymore, whereas the mIgM-BCR still mediated some Ca2+ flux.  
 
Thus, to study the ITAM signaling pathway in both BCR isotypes, I analyzed 
phosphorylation of Ig upon BCR stimulation in wild-type DG75 cells (Fig. 20A). mIgM-
BCR stimulation induced a strong Ig phosphorylation, whereas stimulation of the WT 
mIgE-BCR produced a very weak phospho-Ig signal. The same anti-human-IgE antibody 
was used earlier and induced very efficient Ca2+ signaling in the very same cells (Fig. 
19A). These data would thereby indicate that the mIgE-BCR is mostly using the ITT for 
signaling with only little ITAM activation.  
 




Figure 19: The mIgE-BCR is more dependent on Grb2 and Grap than the mIgM-BCR for signaling in 
DG75 B cells. 
Comparison of Ca
2+
 mobilization kinetics of wild-type DG75 cells (wt) and GRB2/GRAP dKO cells (dKO) 
expressing a WT-ITT-containing mIgE-BCR. Cells were stimulated with the indicated concentrations of anti-
human-IgE antibody (anti-IgE) (A-C) or anti-human-IgM F(ab)’2 fragments (anti-IgM) (D-F). Data are 
representative of three independent experiments. 
 
 
I wanted to validate the observation of minimal mIgE-BCR-induced Ig phosphorylation 
through another complementary approach. Since I had previously found that the Grb2 
SH2 domain efficiently purified phospho-Ig (Fig. 18), I used this SH2 domain as an 
affinity matrix to purify Ig upon mIgM- and mIgE-BCR stimulation (Fig. 20B). Upon mIgM-
BCR stimulation of DG75 cells, the Grb2 SH2 domain purified large amounts of phospho-
Ig, whereas mIgE-BCR stimulation lead to very little phospho-Ig being purified. The IgE 
stimulation was successful since the ITT got phosphorylated and the phosphorylated 
mIgE molecule was efficiently purified. Thus, I conclude that there is minimal Ig 
phosphorylation by the mIgE-BCR in DG75 cells. As a side note, the Grb2 SH2 domain 
also purified the co-stimulatory molecule CD19 upon both mIgE- and mIgM-BCR 
stimulation. This indicates an isotype-independent role of the Grb2-CD19 complex upon 
BCR stimulation, which would require detailed investigation in the future. 
 





Figure 20: The mIgE-BCR signals despite minimal interaction with Ig/Ig in DG75 B cells. 
(A) Wild-type DG75 cells expressing WT mIgE-BCRs were left unstimulated (0) or stimulated for 2 or 5 min 
with either 20 g/ml anti-human-IgM F(ab)’2 fragments (-IgM) or 10 g/ml anti-human-IgE antibody (-IgE). 
Cell lysates were prepared and Ig-ITAM phosphorylation was detected by SDS-PAGE and immunoblotting 
with an anti-phospho-Ig antibody. Anti-Syk was used as loading control and the quantified ratio of phospho-
Ig is indicated below. (B) The same cells as in (A) were stimulated for 3 min with 20 g/ml anti-human-IgM 
F(ab)’2 fragments (-IgM) or 10 g/ml anti-human-IgE antibody (-IgE). Cell lysates were mixed with 15 g 
GST-tagged functional Grb2 SH2 domain (WT), the SH2 domain mutant (R86L) or GST only, along with 
glutathione beads to purify interaction partners. Purified proteins were analyzed by SDS-PAGE and 
immunoblotting. Phosphorylated interaction partners of the Grb2 SH2 domain were analyzed by the p-Tyr-100 
antibody. The blot was also probed with antibodies against Ig, IgE, CD19 and GST. (C) The surface pool of 
mIgE- or mIgM-BCRs was affinity purified by incubating cells for 5 min on ice with either 10 g/ml anti-human-
IgE-Biotin (IgE) or 10 g/ml anti-human-IgM-Biotin (IgM) antibodies respectively. Cell lysates were incubated 
with Streptavidin beads for BCR purification. Interaction with Ig, Ig was detected using SDS-PAGE and 
immunoblotting with antibodies against the proteins. Anti-IgM, anti-IgE and anti-kappa light chain antibodies 
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The limited amount of Ig phosphorylation in the context of the mIgE-BCR raised the 
question of whether the mIgE molecule associates with the Ig/Ig heterodimer. 
Additionally, the amount of mIgE on the cell surface could be much less than that of the 
endogenous mIgM-BCR, which could also account for the observed differences in Ig 
phosphorylation. To test these theories, I purified the cell surface fraction of mIgM- and 
mIgE-BCRs from wild-type DG75 cells using biotinylated antibodies against the heavy 
chains of these proteins (Fig. 20C). To directly compare the amount of purified mIg 
isotype using the same detection system, I analyzed the levels of the kappa light chain 
present in the mIgM and mIgE purification samples. I found that the mIgE-associated 
kappa light chain levels are slightly less but still comparable to the mIgM-bound kappa 
light chain levels (Fig. 20C top panel). Also, large amounts of Ig/Ig were co-purified 
along with mIgM, whereas close to undetectable levels of Ig/Ig were co-purified with 
mIgE. To be noted here is the fact that the antibody used for purification of the BCRs is 
different in both cases (anti-IgM or anti-IgE), which could contribute to differences in 
purification capabilities of intact BCR complexes. Furthermore, there are some reports 
that the stability of the mIg and the Ig/Ig heterodimer can be different for different mIg 
isotypes and is influenced by the detergents used for purification of BCR complexes 
(Schamel and Reth 2000). Hence, I could not at this stage exclude varied complex 
stability as a reason behind differences seen in Ig/Ig association with mIgM and mIgE.   
 
To overcome the limitations associated with differences in complex stability, I employed a 
system to analyze cells expressing only mIgM or mIgE on the cell surface. I could then 
compare surface mIg versus Ig levels in intact cells without introducing purification 
related biases. To achieve this, I used another human Burkitt lymphoma cell line called 
Ramos. Like DG75 cells, Ramos cells also express an endogenous mIgM-BCR which 
contain a lambda light chain. I used a knockout clone of these cells lacking the Ig heavy 
chain (H) and the Ig light chain (L) (here on referred to as Ramos HL KO) (kindly provided 
by the lab of Michael Reth, Freiburg). I confirmed the lack of human  heavy chain 
expression in these cells (Fig. 21A upper panel). The cells still express intracellular Ig 
and Ig (Fig. 21A) but the proteins do not make it to the cell surface in the absence of 
mIgM (data not shown). This is an ideal genetic background to introduce either mIgM or 
mIgE and analyze the cell surface composition of the BCR complex for cells expressing a 
single mIg isotype.  
 
I first reconstituted the Ramos HL KO with a mouse lambda-1 Ig light chain and 
subsequently brought in the 4-hydroxy-3-nitrophenylacetyl NP-specific human m or 
human ms Ig heavy chains. NP is a hapten that is commonly used as a model antigen to 
study antigen-specific B cell responses. The resulting Ramos HL KO cells expressed NP- 
specific mIgM- or mIgE-BCRs where the epitope binding region is completely identical for 
both isotypes (Schematically depicted in Fig. 21B).  
 
 





Figure 21: The human mIgE molecule can pair with Ig/Ig heterodimer. 
(A) Lysates from the human Burkitt lymphoma cell line, Ramos in wild-type (wt) and heavy chain/lambda light 
chain deficient (HL KO) backgrounds were analyzed by SDS-PAGE and immunoblotting. The blot was probed 
with antibodies against human IgM, Ig, Ig and Grb2. (B) Experimental setup. The Ramos HL KO cells were 
reconstituted with the mouse lambda-1 light chain by using a 1-IRES-GFP construct and sorting for GFP-
positive cells. The cells were further reconstituted with either NP-specific human m or m heavy chains giving 
rise to cells expressing either mIgM-BCRs or mIgE-BCRs with NP-reactivity. Flow cytometric analysis of 
surface lambda light chain (LC) (C) and Ig (D) for mIgM-BCR (IgM) or mIgE-BCR (IgE) expressing cells. 
The mean florescence intensity (MFI) is given on the right side of each panel. (E) The normalized ratio of 
LC:Ig was calculated as indicated for mIgM- and IgE-BCRs. Data are representative of one experiment. 
 
 
Next, I determined the surface levels of the lambda light chain (Fig. 21C) and Ig (Fig. 
21D) on cells expressing either mIgM or mIgE.  It is known that mIgM associates with the 
Ig/Ig heterodimer in a 1:1 stoichiometry (Schamel and Reth 2000). With this 
information, one could calculate the normalized ratio of lambda light chain (LC) versus 
Ig and set it to 1.0 for the mIgM-BCR. The normalized ratio of LC versus Ig for mIgE-
BCRs was found to be 1.27 (Fig. 21E). This means that there were more LC molecules 
than Ig molecules associated with the mIgE-BCR. In other words, about 21% of mIgE 
molecules that made it to the cell surface were not associated with Ig. These results 
show that mIgE-BCRs can associate with Ig/Ig. However they also hint towards a 
population of mIgE molecules that may not be associated with Ig/Ig at the cell surface.  
 
 





Figure 22: The human IgE molecule can be expressed on B cells as a functional signaling unit in the 
absence of the Ig-Ig heterodimer. 
(A) Lysates from wild-type Ramos (wt) and Ig deficient (Mb1 KO) Ramos cells were analyzed by SDS-PAGE 
and immunoblotting. The blot was probed with antibodies against Ig, Ig, IgM and Grb2. (B and C) Ramos 
Mb1 KO cells were transfected with human-m-IRES-GFP, WT or ITT-YA mutant human-m-IRES-GFP 
retroviral expression constructs and sorted for GFP-positive cells. (B) Surface mIgM vs. GFP levels were 
analyzed by flow cytometry (middle panel denoted as IgM) along with untransfected and wild-type Ramos 
cells as controls (Left and right panels respectively). (C) Surface mIgE vs. GFP levels were analyzed by flow 
cytometry (middle and right panels denoted as WT and YA) along with untransfected cells (left panel). (D) 
Flow cytometric analysis of surface Ig on WT and ITT-YA mIgE-expressing Mb1 KO cells with wild-type 
Ramos cells (Ramos wt) as control. (E) Ca
2+
 mobilization in Ramos Mb1 KO cells expressing the WT and ITT-
YA mIgE molecules upon stimulation with 10 g/ml anti-human-IgE antibody. (F) Ca
2+
 mobilization in Ramos 
Mb1 KO cells expressing the WT mIgE molecule in the absence (WT) or presence of 30 M Bay61-3606 Syk 
kinase inhibitor (WT+Bay61) following stimulation with 10 g/ml anti-human-IgE antibody. Data are 
representative of one (A, B, C and D) or three (E and F) independent experiments. 
 
 
To test whether a functional mIgE molecule can be expressed on the cell surface without 
the Ig/Ig heterodimer, I used Ramos cells deficient in Ig (Ramos Mb1 KO) (Kindly 
provided by the lab of Michael Reth, Freiburg). These cells lack Ig expression but 
express intracellular Ig and the  heavy chain (Fig. 22A). However, due to the absence 
of Ig, a functional mIgM-BCR cannot be assembled and hence these cells lack surface 
mIgM (data not shown).  I introduced the same NP-specific m and ms heavy chains 
described above into the Ig-deficient Ramos cells. The heavy chains were introduced as 
IRES-GFP constructs to facilitate sorting for GFP-positive transfectants. There was no 
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mIgM detected on the surface in the absence of Ig (Fig. 22B). However, the human 
mIgE (WT and ITT-YA mutant) were efficiently expressed on the surface of these cells 
(Fig. 22C). The mIgE-expressing cells were also confirmed to lack surface Ig expression 
eliminating the possibility of mIgE-Ig-Ig complexes (Fig. 22D). These data show for the 
first time that a transmembrane segment containing mIg molecule, namely human mIgE, 
can be expressed on the surface of B cells without the Ig/Ig heterodimer. 
 
I also analyzed the functional capabilities of the mIgE-ITT in the Ig-deficient Ramos cells 
and found that the ITT could still mobilize Ca2+ in the absence of Ig and Ig, albeit to a 
lesser extent than in wild-type DG75 cells where Ig-Ig are present (Fig. 22E, compare 
to Fig. 19A). Subsequently, I analyzed whether the Ig-Ig-independent activation of the 
ITT required the catalytic activity of Syk because traditionally Syk is known to be recruited 
to the BCR via the ITAMs. Interestingly, inhibition of Syk function using a Syk inhibitor 
completely abolished mIgE-ITT signaling (Fig. 22F). Thus, human mIgE can be expressed 
on the surface of B cells in the absence of Ig/Ig and mediates some signaling which is 
dependent on the kinase Syk. Additionally, this brings to light a novel recruitment 
mechanism of Syk to the mIgE in the absence of the Ig/Ig ITAMs.  
 
To analyze which region of the mIgE molecule imparted it with the ability to be expressed 
in the absence of Ig/Ig, I equipped mIgM with certain segments of mIgE. One chimera 
was generated by replacing only the cytoplasmic tail of mIgM with that of mIgE (mIgM/E-
Cyt). Another chimera consisted of mIgM containing the mIgE transmembrane region and 
cytoplasmic tail (mIgM/E-TM+Cyt). Amino acid sequences and schematic representations 
of the chimeras along with the wild-type mIgM and mIgE molecules are depicted in Fig. 
23A and B respectively. I expressed these chimeric mIgs in the Ramos Ig-deficient cells 
to test whether the transmembrane or cytoplasmic region can provide a gain of function 
property to the mIgM molecule allowing Ig/Ig-independent expression. I found that both 
chimeras, mIgM/E-Cyt and mIgM/E-TM+Cyt, could be expressed on the cell surface 
without Ig and Ig (Fig. 23C). Lack of wild-type mIgM expression provided a good 
negative control in this setting. Note that the BCR-negative populations in the expression 
profiles of mIgM/E-Cyt, mIgM/E-TM+Cyt and mIgE represent untransfected cells that did 
not die after treatment with the selection antibiotic. Equipping the mIgM molecule with the 
cytoplasmic tail segment from human mIgE is sufficient to express mIgM on the cell 
surface in an Ig/Ig-independent manner. Moreover, the mIgE transmembrane segment 
does not seem to be essential for this process. Thus, the cytoplasmic tail of the human 
mIgE molecule provides this isotype with the capability to be expressed without Ig/Ig. 




Figure 23: The cytoplasmic tail of human mIgE is sufficient to mediate Ig/Ig-independent 
expression. 
(A) Single letter amino acid sequence alignment of the transmembrane (TM) and cytoplasmic (Cyt) regions of 
the human mIgM (m) and mIgE (m) variants used. The transmembrane region is marked in grey and the 
mIgE-ITT motif is highlighted in blue (B) Experimental setup. The cytoplasmic tail alone or the transmembrane 
and cytoplasmic regions of human mIgE were fused to the human mIgM heavy chain to produce chimeras 
called mIgM/E-Cyt or mIgM/E-TM+Cyt respectively. Using the wild-type mIgM and mIgE molecules as 
controls, the chimers were retrovirally transduced into Ramos Mb1 KO cells. (C) Surface expression of mIgM, 
mIgM/E-Cyt, mIgM/E-TM+Cyt and mIgE was analyzed by flow cytometry. Data are representative of two 
independent experiments. 
 
Finally, there have been some reports of mIgE expression in mouse and human plasma 
cells in vivo (Yang et al 2012, He et al 2013, Talay et al 2014, Ramadani et al 2016). It 
was not tested whether mIgE is expressed with or without Ig or Ig. Normally, plasma 
cells lose expression of the mIg (at least IgM, IgG and IgA secreting plasma cells) and 
instead produce large amounts of the secreted antibody. Thus, I decided to analyze 
whether human mIgE can be expressed on the surface of plasma cells in the absence of 
Ig/Ig. I used the mouse plasma cell line J558L to introduce the human m and human 
ms heavy chains. J558L cells have lost the capability to produce an endogenous heavy 
chain and Ig and express some intracellular Ig and the lambda light chain (Hombach et 
al 1990). Upon analysis of transfected cells, I found that mIgM could not be expressed on 
the surface of these cells (Fig. 24A). On the other hand, human mIgE is expressed on the 
cell surface of J558L plasma cells (Fig. 24B). To confirm intracellular m expression in 
these cells, I analyzed cell lysates by immunoblotting for human IgM (Fig. 24C). Thus, 
human mIgE, but not mIgM, can be expressed on the surface of plasma cells in the 
absence of the Ig/Ig heterodimer.  





Figure 24: The human mIgE molecule can be expressed on terminally differentiated plasma cells. 
The J558L mouse plasma cell line was transfected with human-m-IRES-GFP and human-m-IRES-GFP 
retroviral expression constructs and sorted for GFP-positive cells. GFP versus surface mIgM (A) and mIgE (B) 
expression was analyzed by flow cytometry. Untransfected J558L cells were used as negative control for 
mIgM and mIgE staining. (C) Intracellular mIgM expression in J558L transfected with mIgM was tested by 
analyzing cell lysates by SDS-PAGE and immunoblotting with an anti-IgM antibody. Parental J558L cells (-) 




In conclusion, the human mIgE molecule is very distinct from mIgM in that it can be 
expressed on B cells in the absence of the Ig/Ig heterodimer, a feature that is imparted 
by the cytoplasmic tail of mIgE. Moreover, the mIgE-ITT can signal in the absence of 
Ig/Ig via a novel Syk-dependent mechanism, the physiological role of which would be of 
great interest for future investigations. 





The biology of IgE memory B cell responses is only beginning to be understood. The 
scarce nature of “true” mIgE-expressing memory B cells makes them extremely difficult to 
analyze in vivo. However, the phase in the life of an IgE memory B cell where it expresses 
a mIgE-BCR is important for the generation of IgE antibody responses as is evidenced by 
the lack of serum IgE in mice that cannot express mIgE (Achatz et al 1997). Therefore, 
examining mIgE-BCR signaling is a critical starting step towards uncovering the 
mechanisms that regulate IgE memory. To understand the composition and signaling 
properties of mIgE-BCRs in detail, I studied human mIgE in B cell lines. Using an anti-IgE 
antibody as a substitute for antigen, I could study the intracellular signaling mechanisms 
of mIgE-BCRs following their stimulation. I made the following key observations in the 
course of my work: 
 
 The ITT motif in the cytoplasmic tail of the mIgE molecule is the principle signal 
amplification device of mIgE-BCRs. 
 The mIgE-ITT reduces the threshold for activation of mIgE-BCRs, leading to enhanced 
Ca2+ mobilization and ERK MAP kinase activation. 
 Upon phosphorylation by the tyrosine kinase Syk, the adaptor proteins Grb2 and Grap 
are recruited to the mIgE-ITT and can independently contribute to ITT-mediated signal 
amplification. 
 Grb2 and Grap are also required for optimal canonical ITAM-induced Ca2+ signaling of 
mIgM-BCRs via their effect on activation of the Ca2+ initiation complex proteins. 
 Unlike mIgM, the human mIgE molecule can be expressed on the B cell surface in the 
absence of Ig and Ig, a feature which is dependent on the mIgE cytoplasmic tail.  
 The mIgE-ITT can signal independently of the Ig/Ig heterodimer in a Syk-dependent 
manner. 
 
4.1 BCR signal amplification by the ITT signaling module in the context of 
mIgE-BCRs. 
 
The ITT motif was previously described as a BCR signal amplification device present in 
the cytoplasmic tail of mIgG, which also augments serum IgG1 production in vivo (Engels 
et al 2009, Lutz et al 2015).  The mammalian mIgG and mIgE Ig isotypes are separated 
from their common ancestor, mIgY by a time span of approximately 200 million years 
(Flajnik 2002). Despite the evolutionary distance, the ITT motif core comprising the YxN 
amino acid sequence is completely conserved in these mIg isotypes. I analyzed the ITT 
motifs in the mIg cytoplasmic tails of these isotypes by comparing the wild-type ITT-
containing BCR to ITT-YA mutant variants. My work revealed that all these isotypes 
contain a functional ITT motif which can mediate BCR signal amplification as measured by 
enhanced Ca2+ mobilization. The evolutionary conservation of ITT-mediated signaling in 
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mIgG, mIgE and even mIgY memory-type BCRs emphasizes the importance of this 
process in B cells (Engels et al 2014). Furthermore, in the context of mIgE-BCRs, I 
demonstrated that the ITT is the only BCR signal amplification device in the cytoplasmic 
tail of mIgE, since deletion of most of the tail led to the same impairment in BCR signaling 
as the ITT-YA mutation. Combined, these observations prove that the ITT motif is the 
predominant signal amplification device in the cytoplasmic tail of memory-type BCRs. 
 
Monitoring Ca2+ mobilization is a commonly used readout for B cell activation since this 
pathway leads to the activation of proteins that are involved in B cell activation, 
proliferation and differentiation (Feske 2007, Baba and Kurosaki 2011). Additionally, the 
ERK MAP kinase pathway is also critical for B cell activation and differentiation into 
plasma cells (Yasuda et al 2008, Yasuda et al 2011). I observed that the mIgE-ITT 
improves activation of both of these signaling pathways. Furthermore, the ITT motif 
increases the sensitivity of mIgE-BCRs towards antigen, leading to prompt activation of 
BCR signaling pathways even at low antigen concentrations. In an in vivo situation, this 
would provide mIgE-expressing B cells with a competitive advantage over cells lacking an 
ITT motif as the mIgE-ITT would allow swifter B cell activation. mIgE-expressing GC B 
cells have been described to rapidly undergo differentiation into plasma cells (Yang et al 
2012). Although the in vivo significance of the mIgE-ITT is yet to be examined, one could 
envision that the ITT would help in the preferential activation and differentiation of mIgE-
expressing B cells thereby augmenting IgE responses.  
 
I could also show that mIgE-ITT phosphorylation requires the catalytic activity of the 
tyrosine kinase Syk. Phosphorylation by Syk leads to the generation of a phospho-
tyrosine binding site for SH2 domain-containing proteins like Grb2, making it the most 
likely candidate to connect the mIgE-ITT with downstream signaling pathways. 
Unexpectedly, the mIgE-ITT did not completely lose its signal amplification capabilities in 
GRB2-deficient B cells, which indicated the presence of a second direct interaction 
partner for the ITT. Analysis of the ITT motif core sequence (YxN) in more detail 
suggested that the tyrosine and asparagine residues are critical for mIg-ITT function. This 
led me to discovering Grap, a Grb2 family member that also prefers a phospho-YxN-
containing binding sequence, as a second functional interaction partner for the mIgE-ITT. 
The wild-type mIgE-BCR could not amplify BCR signaling in GRB2/GRAP double-deficient 
cells and reconstitution with either or both adaptor proteins could rescue the phenotype by 
reviving mIgE-ITT signal amplification. In summary, I found that both Grb2 and Grap are 
utilized by mIgE-BCRs for signal amplification via the ITT.  
 
Our group previously demonstrated that the mIgG-ITT signals exclusively via the adaptor 
protein Grb2. Grb2 equips the mIgG-ITT with signal amplification properties by recruiting 
the kinase Btk to the ITT signalosome. The N-terminal SH3 domain of Grb2 can bind Btk 
whereas Grap cannot (Engels et al 2014). Therefore, although the mIgG-ITT can bind to 
Grap, the inability of Grap to recruit Btk makes it dispensable for mIgG-ITT signaling.  
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So then how does Grap enable ITT-mediated signal amplification in the context of mIgE-
BCRs? There are some Btk-independent mechanisms operating in the context of both 
mIgG- and mIgE-BCRs as is evidenced by some residual ITT signaling in BTK-deficient B 
cells (Engels et al 2014, data not shown). It is possible that these mechanisms are more 
prevalent in the context of mIgE-BCRs making Grap as effective as Grb2 in mIgE-ITT-
mediated signal amplification. In agreement with this hypothesis is my observation that the 
Btk-binding N-terminal SH3 domain of Grb2, when mutated, can still enhance mIgE-BCR 
induced Ca2+ signaling as efficiently as wild-type Grb2. It is also important to note that the 
cytoplasmic tail of mIgE and mIgG are highly conserved at the ITT motif but the rest of the 
tail segment shows quite some variation. These unique amino acid residues of the mIgE 
tail could contribute to recruitment of certain proteins that support Grb2 and Grap in 
carrying out their function at the mIgE-ITT. Even though the exact mechanisms need 
future investigation, to my knowledge this is the first study to implicate Grap as a positive 
regulator of BCR-mediated Ca2+ signaling.  
 
Furthermore, I observed that cytosolic Ca2+ mobilization was not the only process that was 
affected by the absence of Grb2 and Grap, but mIgE-BCR-induced ERK activation was 
also severely impaired. The contribution of Grb2 and Grap in the activation of ERK is 
easier to understand since both proteins can bind to the GEF, Sos (Li et al 1993, data not 
shown), which can then initiate ERK activation via the Ras-MAPK pathway (Buday et al 
1994, Kumar et al 1995). Therefore, I could show that Grb2 and Grap couple the mIgE-
ITT to the ERK MAP kinase signaling pathway. 
 
In conclusion, the mIgE-ITT upon phosphorylation by Syk, recruits the adaptor proteins 
Grb2 and Grap to mIgE-BCRs, leading to enhanced Ca2+ signaling and improved 
activation of the ERK MAPK pathway (see Fig. 25). This equips mIgE-expressing B cells 
with the chance to be activated even at low concentrations of antigen. Although IgE 
memory B cells are scarce, prompt activation of these cells via their high sensitivity BCRs 
would nevertheless amount to a biologically functional level of IgE responses against 
pathogens like helminths. 
 
4.2 The complex role of adaptor proteins in BCR signaling - regulation of 
ITAM signaling by Grb2 and Grap. 
 
A mIgM-BCR consists of a mIgM molecule associated non-covalently with the Ig/Ig 
heterodimer. The mIgM contains a very short cytoplasmic tail without any known signaling 
capabilities (Reth 1992). Therefore, antigen-induced mIgM-BCR signaling is solely 
mediated by the ITAMs in the cytoplasmic tails of Ig and Ig (Kim et al 1993).  Analysis 
of mIgM-BCR signaling in the GRB2/GRAP double-deficient cells revealed that the 
absence of these adaptors impairs optimal activation of canonical ITAM-induced Ca2+ 
mobilization.  






Figure 25: Grb2 and Grap are involved in mIgE-ITT-mediated BCR signal amplification and also 
contribute to canonical ITAM-mediated Ca
2+
 signaling of mIgE- and mIgM-BCRs.  
Illustration depicting the findings of this study regarding the molecular mechanisms dictating mIgE-ITT function 
and the role of Grb2 and Grap in canonical ITAM signaling. Upon activation of the mIgE-BCR, the mIgE-ITT is 
phosphorylated by the tyrosine kinase Syk. This leads to recruitment of the adaptor protein Grb2 and Grap, 
both of which can mediate mIgE-BCR signal amplification via enhanced Ca
2+
 mobilization and ERK MAP 
kinase activation. Additionally, the optimal activation of the Ca
2+
 initiation complex proteins Syk, SLP65 and 
PLC2 requires the presence of Grb2 and Grap, thereby promoting cytosolic Ca
2+
 flux via ITAMs. Grb2 may 
be recruited to Ig, whereas the localization of Grap at the BCR remains unknown. Both proteins may 
additionally be recruited to the membrane via binding to the co-stimulatory molecule CD19 following BCR 
stimulation. Dashed lines represent indirect effects and solid line represent direct effects. Purple-kinases, 
green-adaptor proteins and Ig/Ig heterodimer, red-CD19 and Ca
2+






This is accompanied by reduced phosphorylation and thus activation of  the BCR-proximal 
signal effector proteins Syk, SLP65 and PLC2 that control the Ca2+ signaling pathway. 
Analysis of the individual domains of Grb2 and Grap brought me a step closer to 
understanding their functional contribution to the Ca2+ signaling pathway. The SH2 
domain is required for Ca2+ signaling since it most likely recruits these adaptors to the 
active BCR signalosome. In regard to this, I could identify the BCR itself (Grb2) or to the 
co-stimulatory molecule CD19 (Grb2 and Grap) as binding sites for the adaptors following 
BCR stimulation. Upon mIgM-BCR stimulation, the N-terminal SH3 domains of Grb2 and 
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Grap are critical for Ca2+ mobilization. On the other hand, mIgE-BCR induced Ca2+ flux 
utilizes either Grb2 SH3 domain but is reliant on a functional N-terminal SH3 domain of 
Grap. The functional differences displayed by the SH3 domains at the mIgM- and mIgE-
BCRs imply that there are different routes used to activate Ca2+ signaling by different BCR 
isotypes. This may be partly explained by the fact that compared to mIgM-BCRs, which 
only have the ITAMs in Ig/Ig, mIgE-BCRs also contain an ITT motif and hence Grb2 
and Grap could be employing different molecular mechanisms at these two motifs to 
activate the Ca2+ signaling pathway. In conclusion, the functional role of Grb2 and Grap is 
not limited to the mIgE-ITT (as discussed in the previous section), but also extends to the 
canonical ITAM-signaling pathway. 
 
I can propose some explanations as to how Grb2 and Grap might positively modulate 
ITAM-induced Ca2+ signaling. One explanation is that Grb2 and Grap act upstream of Syk 
in the BCR signaling cascade and thereby affect activation of the Ca2+ initiation complex. 
In fact, it has been reported that in T cells, Grb2 acts at a very early stage of T cell antigen 
receptor signaling by positively modulating the activity of the tyrosine kinase Lck (Jang et 
al 2010), which is the T cell functional homologue of Lyn in B cells. A similar concept 
might be applicable to B cells, where Grb2 and Grap help in optimal Lyn-mediated 
activation of Syk, PLC2 and SLP65. The main biological role of adaptor proteins is to 
nucleate signalosomes by recruiting and/or stabilizing protein complexes. Both Grb2 and 
Grap can at least associate directly with SLP65 (Engels et al 2014), though the complete 
interactome of Grb2 and Grap in human B cells needs elucidation. The presence of Grb2 
and Grap at the signalosome could additionally increase the local concentration of 
signaling proteins recruited by these adaptors by virtue of their SH3 domains. This would 
then help in the optimal activation of the recruited proteins and simultaneously facilitate 
signal amplification as well. 
 
The recruitment of Grb2 and Grap to the co-stimulatory molecule CD19 (this study) may 
also be functionally relevant. Co-ligation of CD19 with the mIgM-BCR has been shown to 
increase BCR-induced Ca2+ signaling (Fujimoto et al 2001). CD19 induces activation of 
PI3K, a protein that regulates Ca2+ signaling by increasing the local concentration of PIP3 
at the plasma membrane, which then serves as membrane anchor for many BCR 
signaling proteins including Btk and PLC2 (Buhl and Cambier 1999, Jou et al 2002, 
Okkenhaug and Vanhaesebroeck 2003). Additionally, interaction of the Btk PH domain 
with PIP3 has also been associated with allosteric activation of Btk kinase activity (Saito et 
al 2001). How PI3K is activated following BCR stimulation is not completely understood. It  
would be interesting to analyze whether Grb2 and Grap can modulate PI3K activity 
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The functional role of Grb2 has not been well studied in B cells, accompanied by almost 
no insight into the function of Grap. The current standing in the field is that Grb2 
negatively regulates mIgM-BCR signaling. This is based on some reports that observed 
enhanced Ca2+ flux in the absence of Grb2 in either a chicken B cell line or mouse models 
(Stork et al 2004, Ackermann et al 2011, Jang et al 2011). It is important to point out that 
Grb2 also interacts with proteins like SH2 domain-containing inositol phosphatase 1 
(SHIP1), CD22 and downstream of tyrosine kinase 3 (Dok3), all of which are negative 
regulators of BCR signaling (Neumannn et al 2009, Stork et al 2007, Poe et al 2000).  
However, my data presents a positive role for Grb2 (and Grap) in BCR-induced Ca2+ 
signaling in human B cells. Although I cannot exclude species-specific differences 
influencing the function of Grb2, the high degree of homology between the human and 
mouse orthologs makes functional conservation seem quite likely. B cell-specific Grb2-
deficient mice show considerable impairment in the development of mature B cells 
(Ackermann et al 2011, Jang et al 2011). Given that proper BCR signaling is critical for 
normal B cell development (Melchers et al 1993, Reth and Nielson 2014), these mice 
perhaps never received signals required to give rise to a normal B cell compartment 
leading to hyper-responsiveness on BCR stimulation. B cell maturation phase-specific 
conditional Grb2-deficient mice would perhaps provide clearer answers to whether Grb2 
also plays a positive role in mIgM-BCR signaling in mice.  
 
In contrast to the supposed negative role of Grb2 in BCR signaling, Grb2-deficient mice 
display reduced serum IgG titers (Ackermann et al 2011). Supporting this is the 
observation that activation of IgG-switched memory B cells and their differentiation into 
IgG-secreting cells requires Grb2 in vivo (Engels et al 2014). Thus, it is possible that Grb2 
has a more complex role in regulating BCR signaling, where it can play a positive or a 
negative role depending on the site of recruitment - the BCR, CD19, CD22 or Dok3. 
 
Unlike Ca2+ signaling, I found that BCR-induced activation of ERK requires all three 
domains of Grb2 and Grap to be functional. This can be explained by the fact that binding 
of Sos to both Grb2 SH3 domains stabilizes this interaction as compared to the low affinity 
binding to only one of the SH3 domains (Simon and Schreiber 1995). Moreover, it is also 
important to highlight the fact that the absence of Grb2 and Grap leads to an almost 
complete block in ERK activation whereas Ca2+ signaling is not as drastically reduced 
(see Fig. 16 and 17). These observations imply that Ca2+ and ERK signaling pathways are 
not directly coupled as their activation require different domains of the adaptors to be 
functional and that perhaps different pools of Grb2 and Grap diversify the initial BCR 
signal either into the Ca2+ pathway or the ERK pathway.   
 
Based on the data from this study, I propose that Grb2 and Grap can positively regulate 
ITAM-induced Ca2+ signaling in human B cells (see Fig. 25). The utilization of different 
adaptor proteins like Grb2 and Grap by the BCR probably helps improve B cell activation 
via both signal amplification as well as signal diversification. 
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4.3 It all comes down to the tail - human mIgE expression and ITT signaling 
in the absence of Ig/Ig.  
 
A single unit of the mIgM-BCR consists of mIgM and the Ig/Ig heterodimer in a 1:1 
stoichiometry wherein the signaling function is mediated by the ITAMs in the cytoplasmic 
tails of Ig and Ig (Schamel and Reth 2000, Kim et al 1993). Similarly, the mIgE-BCR is 
believed to be composed of mIgE plus Ig/Ig, with the exception that the longer mIgE 
cytoplasmic tail has an additional ITT motif signaling module. The mIgE-ITT is completely 
non-functional in the absence of the adaptor molecules Grb2 and Grap (this study). 
Therefore, in the absence of Grb2 and Grap, the mIgE-BCR should only signal via the 
ITAMs in Ig and Ig, making its signaling capabilities similar to that of mIgM-BCRs. 
Surprisingly, this was not the case, since I could observe a much stronger impairment in 
Ca2+ signaling for mIgE-BCRs compared to mIgM-BCRs in GRB2/GRAP double-deficient 
cells. This led me to investigate the ITAM signaling pathway in mIgE-BCRs and I found 
that in DG75 B cells, there was very little activation of ITAMs following mIgE-BCR 
stimulation as exemplified by the lack of Ig phosphorylation. Moreover, I could barely co-
purify any Ig and Ig with surface mIgE whereas surface mIgM associated with 
substantial amounts of these proteins under identical buffer conditions.  
 
One possible explanation for the above mentioned observations would be active 
competition between mIgM and mIgE for the Ig/Ig heterodimer. DG75 B cells normally 
express only mIgM and perhaps introduction of an additional mIgE molecule creates an 
overload for the cellular machinery to produce sufficient Ig/Ig for both isotypes. 
However, additional expression of mIgE did not alter mIgM-BCR expression or signaling 
when compared to cells expressing only mIgM (data not shown). Nevertheless one could 
argue that the expression of two different isotypes may not be normal for a B cell in vivo. 
This is actually not true since, naïve B cells can express both mIgM and mIgD on the 
same cell (Havran et al 1984). More specific to this situation, there are some reports of 
IgM and IgE co-expression in human B cells during on-going class-switch recombination 
although the mIg phenotype of these cells was not clearly analyzed (Mackenzie and 
Dosch 1989, Wesemann et al 2011). Therefore, mIgM and mIgE co-expression may not 
be as improbable as one would normally imagine. 
 
An alternative explanation for the lack of ITAM signaling upon mIgE-BCR stimulation 
would be that there is no association between human mIgE and the Ig/Ig heterodimer. 
Since the DG75 B cells I used, expressed both BCR isotypes on the same cells, I could 
not analyze the Ig/Ig pools associated with the individual mIg isotypes. Therefore, I 
used an Ig heavy and Ig light chain deficient variant of Ramos B cells, which are human 
Burkitt lymphoma cells similar to DG75 B cells. Lack of endogenous heavy chain 
expression enabled independent expression of either mIgM or mIgE in these cells. I could 
show that both mIg isotypes were expressed with surface Ig/Ig, although the ratio of 
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mIg to Ig was a bit more for mIgE-BCRs. Thus, although mIgE can associate with Ig 
and Ig, these results also hinted towards some Ig/Ig-less mIgE molecules on the cell 
surface. Moreover, since the mIgE-ITT-YA and mIgE-tailless mutants are signaling 
competent in B cells, there is probably a pool of Ig/Ig associated with mIgE, mediating 
signaling via the ITAMs. Linking the observations, I conclude that mIgE can associate with 
Ig/Ig although there might also be a fraction of free surface mIgE in B cells. 
 
To conclusively prove the existence of surface mIgE without Ig/Ig, I used Ig-deficient 
Ramos B cells where the absence of Ig also prevents surface expression of Ig. 
Expression of human mIgE in these cells revealed that this mIg can be expressed as a 
stand-alone molecule without the Ig/Ig heterodimer and that the mIgE-ITT can signal in 
the absence of Ig/Ig in a Syk-dependent manner. In contrast, mIgM did not reach the 
cell surface and remained intracellular in the absence of Ig. Furthermore, I found that the 
cytoplasmic tail of mIgE is required for the Ig/Ig-independent surface expression since 
fusing the mIgE cytoplasmic tail to mIgM was enough to express mIgM on the cell surface 
without Ig/Ig.  
 
Mechanistically, these results pose some important questions regarding the surface 
transport and signaling mechanisms utilized by the human mIgE molecule. For instance, 
does the mIgE cytoplasmic tail actively uncouple itself from the Ig/Ig heterodimer or is 
there an ER quality control escape mechanism that allows human mIgE to be transported 
to the cell surface without Ig/Ig? mIgM-BCRs require all components including Ig and 
Ig, to be properly assembled in the ER for transport and expression on the cell surface 
through a not so well understood mechanism. Certain chaperones have been reported to 
associate with the Ig heavy and light chains and to affect their ER processing (Bole et al 
1986, Knittler et al 1995). It would be interesting to investigate whether the short 
cytoplasmic tail sequence of IgM which contains only three amino acids KVK (single letter 
code), somehow acts as an ER retention signal in the absence of Ig/Ig. The human 
mIgE cytoplasmic tail does not have this sequence, and instead contains the  amino acid 
sequence MVQR (single letter code), followed by 24 additional residues which could lead 
to alternative processing mechanisms in the ER. In fact, when I expressed a variant of 
mIgE with only the MVQR residues in the cytoplasmic tail (tailless mIgE variant in Fig. 4), 
this molecule exhibited lower surface expression than wild-type mIgE. This suggests that 
some mIgE cytoplasmic tail-dependent regulatory mechanisms operate in B cells and 
require future investigation. 
 
Another novel finding made by me was that the mIgE-ITT can mediate some Ca2+ 
signaling without Ig/Ig in a Syk-dependent manner. Traditionally, Syk is believed to be 
recruited to the BCR signaling complex via phosphorylated ITAMs (Johnsen et al 1995, 
Kurosaki et al 1995). The results from this study suggest a new mechanism of Syk 
recruitment to the mIg, independently of ITAMs. Additionally, it is also relevant to 
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investigate whether this signaling function of mIgE is completely self-dependent or 
whether some membrane/cytosolic interaction partner can compensate for the absence of 
Ig/Ig? A very recent report implicated that the association between CD19 and mIgE 
promotes autonomous mIgE signaling which culminates in either apoptosis or plasma cell 
differentiation in mice (Haniuda et al 2016). Could CD19 be a surrogate for Ig/Ig in case 
of the human mIgE molecule? Preliminary work in this direction revealed that the human 
mIgE-BCR signals equally efficiently in wild-type and CD19-deficient B cells. Also, I could 
not detect any association between CD19 and human mIgE in biochemical experiments 
(data not shown). Another possibility could be that binding of Grb2 and/or Grap to the 
mIgE-ITT can initiate BCR signaling without Ig/Ig due to their ability to positively 
regulate Ca2+ signaling at a BCR-proximal level, as revealed in this study. Future 
investigation into the mechanism by which the human mIgE-ITT can signal without Ig/Ig 
and whether CD19, Grb2 or Grap are involved in that process may provide some useful 
insights. 
 
From a functional point of view, expression of mIgM in the absence if Ig/Ig would not 
make sense since the signaling function of this BCR isotype solely resides in the ITAMs in 
the cytoplasmic tails of the Ig/Ig heterodimer (Kim et al 1993). Hence, such a molecule 
would not be able to relay any intracellular signaling, even after antigen binding. The 
presence of the ITT in the cytoplasmic tail of mIgE endows some signaling capabilities to 
this isotype even in the absence of the Ig/Ig heterodimer in the GC-like Burkitt B cell 
lines used in this study. In a physiological setting, surface expression of mIgE in the 
absence of Ig/Ig would more likely occur in the last stage of B cell differentiation which 
is plasma cells. Plasma cells do not express any Ig and also switch from expression of 
the mIg to the secreted Ig. I could show that human mIgE can be expressed on the 
surface of plasma cells. Even though the in vivo significance of this Ig/Ig-independent 
ITT signaling process remains to be investigated, it is tempting to speculate that this kind 
of signaling module might affect the fate of mIgE-positive B cells, modulating the 
formation/maintenance of IgE memory. 
 
Remarkably, in-depth analysis of mIgE-positive B cells in mice showed that most of these 
cells were plasma cells (Yang et al 2012, Talay et al 2014). A recent study in which IgE 
plasma cells were generated using in vitro differentiation of human tonsillar B cells also 
reported mIgE expression on the surface of human plasma cells (Ramadani et al 2016). 
There is some evidence of long-lived IgE plasma cells in humans and that these cells may 
contribute to allergic responses (Hallstrand et al 2004, Mitre et al 2006). It would hence be 
crucial to analyze human mIgE-positive long-lived plasma cells in more detail to see if the 
mIgE molecule actively contributes to an ongoing IgE response via ITT signaling. 
Additionally, BCR signaling is not only required for antigen-induced activation but also 
survival of B cells in the absence of any antigen (Werner et al 2010). Therefore, it remains 
to be seen whether mIgE also provides survival signals to plasma cells. Answers to these 
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questions would have useful implications in designing therapy to effectively target all 
mIgE-positive B cells for treating allergies.  
 
Combining my observations, I suggest that the Ig/Ig-independent mIgE-ITT signaling 
module hints toward a novel mechanism regulating the biological activity of the IgE 
memory compartment.  
 
 
4.4 Conclusions and perspectives  
 
The biological role of IgE is to mediate clearance of large pathogens like helminths from 
the body. However, IgE also plays a clinically significant role since it is one of the main 
mediators of immediate hypersensitivity reactions. It is thus important to understand how 
IgE memory B cells are activated so this information can be applied to therapeutically 
target these cells in an effective manner. In this work, I described some molecular 
features of mIgE-BCR signaling, which contribute towards our understanding of IgE 
memory responses. mIgE-BCRs contain the evolutionarily conserved ITT motif in the 
mIgE cytoplasmic tail, which increases the antigen sensitivity of these BCRs via utilization 
of the adaptor proteins, Grb2 and Grap, This leads to prompt activation of BCR-proximal 
signaling pathways in mIgE-expressing cells. Interestingly, the human mIgE cytoplasmic 
tail confers the molecule with the capacity to be expressed as a functional signaling unit in 
the absence of the Ig/Ig heterodimer (see Fig. 26 on next page).  
 
To my knowledge, this is the first report of a mIg isotype having the capacity to relay 
intracellular signals even in the absence of the Ig/Ig heterodimer, which are considered 
necessary for BCR signal initiation based on current textbook models. It would be of 
extreme interest to determine whether this novel signaling mechanism influences the 
formation and/or maintenance of the memory IgE B cell compartment. Moreover, if it turns 
out that plasma cells also express this Ig/Ig-independent signaling competent mIgE 
molecule in vivo, it would be important to consider a more active contribution of mIgE-
positive plasma cells in regulating IgE memory responses via mIgE-ITT signaling.   
 
 





Figure 26: The human mIgE-ITT can function independently of the Ig/Ig heterodimer. 
Illustration depicting the various signaling modules of human mIgE as elucidated in this study. (A) The 
conventional mIgE-BCR complex is composed of the ITAM signaling motifs in the Ig/Ig cytoplasmic tail and 
the ITT motif in the mIgE cytoplasmic tail. (B) The human mIgE can also be expressed on the B cell surface in 
the absence of Ig/Ig. Activation of the mIgE molecule leads to mIgE-ITT mediated Ca2+ signaling which is 
dependent on the tyrosine kinase Syk. Such a module can be expressed on both GC-like B cells and plasma 
cells. Dashed lines represent indirect effects. Purple-tyrosine kinase Syk, green-Ig/Ig heterodimer, blue-
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Table 1: Antibodies used in this study  
Primary antibodies were used at a dilution of 1:1000 and secondary antibodies at 1:10000 
for western blotting. A 1:100 dilution was used for flow cytometry. Antibody concentrations 
for stimulations and affinity purifications can be found in the respective figure legends. 
(WB-western blotting, FC-flow cytometry, S-stimulation, AP-affinity purification) 
 
Antibody Species (Clone) Supplier Application 
-human IgE epsilon 
chain 
Goat (polyclonal) Abcam WB, FC,S 
-human IgE-Biotin Goat (polyclonal) Thermo Scientific AP 
-Goat IgG (H&L)-Alexa 
Fluor 647 F(ab’)2 
Donkey (polyclonal) Abcam FC 
-human IgM F(ab’)2 
fragment 
Goat (polyclonal) Jackson Immuno 
research 
S 
-human IgM-Biotin Goat (polyclonal) Southern Biotech WB, AP 
-human IgM-APC Mouse IgG3 (UHB) Southern Biotech FC 
-human kappa Goat (polyclonal) Southern Biotech WB 
-mouse IgG F(ab’)2 
fragment 
Goat (polyclonal) Jackson Immuno 
research 
S 
-mouse IgG-CY5 Goat IgG (polyclonal) Southern Biotech FC 
-mouse -Biotin Rat IgG2a (RML42) Biolegend FC 
-p-p44/42 MAPK  
(Erk1/2) (Thr202/Tyr204)  
Mouse IgG1 (E10) Cell Signaling 
Technology (CST) 
WB 
-pan Erk Mouse IgG2a (16) BD Biosciences WB 
-p-Tyr-100 Mouse IgG1 (100) CST WB 
-p-Tyr 4G10 Mouse IgG2a (4G10) Upstate 
Biotechnology 
WB 
-Syk Mouse IgG2a (4D10) Santa Cruz WB 
-p-Syk (Tyr323) Rabbit (polyclonal) CST WB 
-PLC2 Rabbit IgG (polyclonal) Santa Cruz  WB, AP 
-p-PLC2 (Tyr759) Rabbit (polyclonal) CST WB 
-SLP-65 Mouse IgG1 BAbCo WB 
-SLP-65 Mouse IgG2a (2B11) BD Biosciences WB 
-p-BLNK (SLP65) Rabbit (polyclonal) CST WB 




-Grb2  Mouse IgG1 (3F2) Millipore WB 
-Grap Goat (polyclonal) Abnova WB 
- actin  Rabbit IgG (13E5) CST WB 
-GST  Rabbit IgG (polyclonal) MoBiTec WB 
-CD79A (Ig) Rabbit  (EP3618) Abcam WB 
-CD79A-AlexaFluor647 Mouse IgG1 (ZL7-4) BioRad FC 
-p-CD79A (Tyr182)  Rabbit  (polyclonal) CST WB 
-CD79B (Ig) Rabbit  (EPR6861) Abcam WB 
-CD79B-AlexaFluor647 Hamster IgG (HM79-11) BioRad FC 
-CD19 Rabbit (polyclonal) CST WB 
-mouse IgG1 -HRP Goat IgG (polyclonal) Southern Biotech WB 
-mouse IgG2a-HRP Goat IgG (polyclonal) Southern Biotech WB 
-mouse IgG2b-HRP Goat IgG (polyclonal) Southern Biotech WB 
-rabbit IgG-HRP Goat IgG (polyclonal) Southern Biotech WB 
-goat IgG-HRP Donkey (polyclonal) Southern Biotech WB 
 
5.1.2 Vectors and constructs 
 
Table 2: Vectors and constructs used in this study 
 
Vector backbone Insert Source 
Vectors used for cloning or as source of insert 
pCRIITOPO - Invitrogen 
pCRIITOPO hmSvnp-WT Niklas Engels 
pCR2.1 - Invitrogen 
pCR2.1 BNN-Vnp This study 
pUC-18 hHCOC25SG Niklas Engels 
pCR2.1 mGRB2-WT Lars M. Koenig 
pCR2.1 hGRAP-WT Lars M. Koenig 
pCR2.1 m1LC Niklas Engels 
Vectors used for retroviral expression of proteins in mammalian cells 
pMSCVpuro - Clontech 
pMSCVpuro hmSvnp-WT Niklas Engels 
pMSCVpuro hmSvnp-YA Niklas Engels 
pMSCVpuro hmSvnp-MVQR This study 
pMSCVpuro hmSvnp-NA This study 
pMSCVpuro 2am-WT Niklas Engels 
pMSCVpuro 2am-YA Niklas Engels 
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pMSCVpuro 2am-m-WT This study 
pMSCVpuro 2am-m-YA This study 
pMSCVpuro hHCvnp This study 
pMSCVpuro hHCvnp/h-Cyt Niklas Engels 
pMSCVpuro hHCvnp/h-TM+Cyt Niklas Engels 
MiGRII - Elena Vigorito 
MiGRII mGRB2-WT This study 
MiGRII mGRB2-W36K This study 
MiGRII mGRB2-R86K This study 
MiGRII mGRB2-W193K This study 
MiGRII hmSvnp-WT This study 
MiGRII hmSvnp-YA This study 
MiGRII hHCvnp This study 
MiGRII m1LC This study 
MiRFP - Lars M. Koenig 
MiRFP hGRAP-WT This study 
MiRFP hGRAP-W36K This study 
MiRFP hGRAP-R86K This study 
MiRFP hGRAP-W195K This study 
pCMV VSV-G Manfred Juecker 
Vectors used for expression of GST fusion proteins in bacteria 
pGEX4T-1 - GE Healthcare 
pGEX4T-1 mGRB2-SH2-WT Niklas Engels 
pGEX4T-1 mGRB2-SH2-R86L Niklas Engels 
pGEX4T-1 hGRAP-SH2-WT This study 




Table 3: Primers used in this study (Fwd-forward, Rev-reverse) 
 
Primer name Primer sequence 5’ - 3’ 
M13 Fwd  TGTAAAACGACGGCCAGT 
M13 Rev  CAGGAAACAGCTATGACC 
pMSCV Fwd CCCTTGAACCTCCTCGTTCGACC 
pMSCV Rev GAGACGTGCTACTTCCATTTGTC 
Anolis YA Fwd CAACAGGCCCTGATGCTAAGAATGTACTCC 
Anolis YA Rev GGAGTACATTCTTAGCATCAGGGCCTGTTG 
huIgE NA Fwd CTCGACTACACCGCCGTCCTCCAGCCCCAC 
huIgE NA Rev GTGGGGCTGGAGGACGGCGGTGTAGTCGAG 
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hIgE MVQRstop Fwd CTCCTCATGGTGCAGCGGTAGCTCTCAGCCACG 
hIgE MVQRstop Rev CGTGGCTGAGAGCTACCGCTGCACCATGAGGAG 
GRAP W36K Fwd GAGGATGACCAGAACAAGTACAAGGCCGAGCTC 
GRAP W36K Rev GAGCTCGGCCTTGTACTTGTTCTGGTCATCCTC 
GRAP R86K Fwd GAGCCTTCCTGATCAAGGAGAGTGAGAGCTC 
GRAP R86K Rev GAGCTCTCACTCTCCTTGATCAGGAAGGCTC 
GRAP W195K Fwd GCCCAGACCCCCACAAGTGGCGGGGCCGGTCCTG 
GRAP W195K Rev CAGGACCGGCCCCGCCACTTGTGGGGGTCTGGGC 
VNP BNN Fwd ATCGGATCCGCGGCCGCTCTCACCATGGGATGGAGCT
GTATC 
VNP BNN Rev ATCGCTCGAGACGGTGACCGTGGTCCC 
 
5.1.4 Synthetic peptides  
 
 Human--phospho-ITT peptide 
Biotin – RPQTSLD(pY)TNVLQPHA 
 Human--ITT peptide 
Biotin – RPQTSLDYTNVLQPHA 
 
1mM stock solution was prepared in 1X PBS. The non-phosphorylated peptide was 
generated by treating an aliquot of the phospho-peptide with calf intestinal phosphatase 
for 1 hour at 37C. The peptides were purchased from CASLO ApS. 
 
5.1.5 Mammalian cell lines 
 
 DG75 (DSMZ ACC 83) 
Human Burkitt lymphoma B cell line established from the pleural effusion of a 10-
year-old boy with Burkitt lymphoma (refractory, terminal) in 1975. The cells were 
described as EBV (Epstein Barr Virus) negative and express mIgM along with the 
 light chain (Ben-Bassat et al 1977).  
 DG75 EcoBlast (EB)  
DG75 cells were transfected with a vector containing the murine cationic amino-
acid transporter 1 (slc7a1) ecotropic receptor for MMLV-based retrovirus docking 
and blasticidin as a selection marker (Tillmann Brummer, Lars M. Koenig, PhD 
thesis, 2012). 
 DG75GRB2KOEN (referred to as GRB2KO in this study) 
DG75 cells deficient for GRB2 were generated using vectors targeting the GRB2 
locus by homologous recombination followed by antibiotic selection. The cells 
were additionally transfected with a vector containing the murine cationic amino-
acid transporter 1 (slc7a1) ecotropic receptor for MMLV-based retrovirus docking 
and neomycin as a selection marker (Engels et al 2014). 
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 DG75GRB2KOENGRAPh#81 (referred to as GRB2/GRAP dKO in this study) 
DG75GRB2KOEN cells were targeted with a TALEN construct targeting the GRAP 
locus generating cells heterozygous for GRAP. The cells have nucleotide deletions 
in each allele leading to almost undetectable levels of Grap protein expression 
(Caren Bartsch, PhD thesis, 2016). 
 Platinum-E (Plat-E) 
Plat-E is a retroviral packaging cell line based on the HEK293T cells. They contain 
the MMLV (Moloney murine leukemia virus) gag, pol and env genes driven by a 
strong EF1 promoter. The presence of an internal ribosome entry site (IRES) site 
between the gag, pol and env genes and the selection markers (blasticidin and 
puromycin) ensures high retroviral titers in these cells (Morita et al 2000).  
 J558L 
J558L is a mouse plasmacytoma B cell line isolated from a BALB/C mouse 
myeloma. The cells are class switched to IgA isotype but do not express it, 
however they secrete a  light chain (Hombach et al 1990). Kindly provided by 
Michael Reth, Freiburg, Germany. 
 Ramos  
Human Burkitt lymphoma B cell line originally established from the ascitic fluid of a 
3-year-old boy with American-type Burkitt lymphoma in 1972. The cells were 
described as EBV-negative and carry the (8;14) IgH;MYC translocation and TP53 
mutations. They express sIgM along with the  light chain (Klein et al 1975). Kindly 
provided by Michael Reth, Freiburg, Germany. 
 Ramos HL KO #39  
Ramos cells deficient for the Ig heavy chain (H) and the Ig lambda light chain (L). 
Kindly provided by Michael Reth, Freiburg, Germany. 
 Ramos Mb1 KO  
Ramos cells deficient for the Mb1 gene encoding for Ig. Kindly provided by 
Michael Reth, Freiburg, Germany.  
 
5.1.6 Cell culture media for mammalian cell lines 
 
 R10 medium 
RPMI 1640 + Glutamax, 10% heat inactivated fetal calf serum (FCS), 1% 
penicillin/streptomycin, 50m -mercaptoethanol, 1mM sodium pyruvate 
 R0 medium 
R10 without FCS 
 Freezing medium 
90% heat inactivated FCS, 10% DMSO 
 Selection markers 
3 g/ml puromycin or 10g/ml blasticidin  
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 “Heavy” SILAC medium for mass spectrometry 
SILAC RPMI 1640 Medium, 10% dialyzed fetal bovine serum (PAN Biotech), 1% 
penicillin/streptomycin, 0.12 mM L-Arginine(13C6),  0.27mM L-Lysine (D4) 
 “Light” SILAC medium for mass spectrometry 
SILAC RPMI 1640 Medium, 10% dialyzed fetal bovine serum (PAN Biotech), 1% 
penicillin/streptomycin 
 
5.1.7 Bacterial strains 
 
 TOP10F - used for cloning 
Genotype – F ́{lacIq Tn10 (TetR)} mcrA ∆(mrr-hsdRMS-mcrBC) Φ80lacZ∆M15 
∆lacX74 recA1 araD139 ∆(ara-leu)7697 galU galK rpsL endA1 nupG 
 BL21 DE3 - used for protein expression 
fhuA2 [lon] ompT gal (λ DE3) [dcm] ∆hsdS λ DE3 = λ sBamHIo ∆EcoRI-B 
int::(lacI::PlacUV5::T7 gene1) i21 ∆nin5  
5.1.8 Media and plates for bacteria 
 
 Luria Bertani (LB) medium  
10 g/L Tryptone, 5 g/L yeast extract, 5 g/L NaCl, pH 7.0. Autoclaved at 121C, 
1.25 bar for 30 min. 
 2X Yeast Tryptone (2YT) medium  
16 g/L Tryptone, 10 g/L yeast extract, 10 g/L NaCl, pH 7.0. Autoclaved at 121C, 
1.25 bar for 30 min. 
 Agar plates 
LB medium, 2% (w/v) agar  
 Selection  markers 
100 g/ml ampicillin 
 
5.1.9 Chemical reagents 
 
All chemicals and reagents used in this work were purchased from Carl Roth, Sigma, 
Merck or Invitrogen unless categorically specified. 
 
5.1.10 Buffers and solutions 
 
Table 4: Buffers and solutions used in this study 
 
Buffer/solution Composition 
B cell lysis buffer 
 
137.5 mM NaCl, 50 mM Tris pH 7.8, 1 mM 
Na3VO4, 0.5 mM EDTA pH 8.0, 10% 
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glycerol, 1X protease inhibitor cocktail, 1% 
NP-40 detergent, add. ddH2O 
1X Phosphate buffer saline (PBS) 137 mM NaCl, 27 mM KCl, 8.6 mM 
Na2HPO4.12H2O, 1.4 mM KH2PO4 , add. 
ddH2O 
1X Krebs ringer solution 140 mM NaCl, 4 mM KCl, 10 mM D-
glucose, 10 mM HEPES pH 7.4, 1 mM 
CaCl2 
1X Tris buffer saline with tween (TBST) 20 mM Tris pH 7.6, 137 mM NaCl, 0.1% 
tween-20, add. ddH2O 
Enhanced chemiluminiscence (ECL) 
solution A 
200 ml 0.1 M Tris pH 8.6, 50 mg luminol  
ECL solution B  50 ml DMSO, 55 mg para-hydroxycoumaric 
acid 
2X Laemlli buffer 62.5 mM TrisHCL pH 6.8, 2% SDS, 20% 
glycerol, 5% -mercaptoethanol, 0.025% 
bromophenolblue, add. ddH2O 
Coomassie staining solution 0.25% Coomassie Brilliant Blue R-250, 
45% methanol, 10% acetic acid, add. 
ddH2O 
10% Resolving gel SDS-PAGE 
 
375 mM Tris pH 8.8, 0.1% SDS, 10% 
Acrylamide and bisacrylamide, 0.00065% 
APS, 0.001% TEMED, add. ddH2O 
5% Stacking gel SDS-PAGE 125 mM Tris pH6.8, 0.1% SDS, 5% 
Acrylamide and bisacrylamide, 0.001% 
APS, 0.001% TEMED, add. ddH2O 
1X SDS-PAGE running buffer 25 mM Tris, 192 mM glycine, 0.1% (w/v) 
SDS, add. ddH2O 
1X Blotting buffer 39 mM Glycine, 48 mM Tris, 0.0375% (w/v) 
SDS, 0.01% (w/v) NaN3, 20% (v/v) 
methanol, add. ddH2O 
Blocking solution 5% BSA, 0.001% NaN3, add. 1X TBST 
1X  Tris acetate EDTA (TAE) 40 mM Tris-acetate pH8.0, 10 mM NaOAc, 
1 mM EDTA, add. ddH2O 
 
 
5.1.11 Enzymes and their supplier 
 
 Restriction endonucleases New England Biolabs  
 T4 DNA Ligase New England Biolabs 
 Calf intestinal phosphatase New England Biolabs 
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 Pfu polymerase  
 Phusion polymerase 
Promega 
New England Biolabs 
 
 
5.1.12 Additional materials and their supplier 
 
 5X Phusion Buffer New England Biolabs 
 6X DNA loading dye Thermo Fischer Scientific 
 10X NEBuffers 2.1/3.1/Cutsmart New England Biolabs 
 10X BSA New England Biolabs 
 10X Pfu Buffer Promega 
 10X T4 Buffer New England Biolabs 
 Blasticidin InvivoGen 
 Bay61-3606 inhibitor Calbiochem 
 Cell culture material Greiner, Sarstedt, Nunc 
 GeneRulerTM 1 kb DNA ladder  Thermo Fischer Scientific 
 Glutathione-Sepharose beads GE Healthcare 
 Indo-1 AM Invitrogen 
 Nitrocellulose filter Hybond ECLTM  GE Healthcare 
 Whatman Gel Blotting Paper GE Healthcare 
 Puromycin InvivoGen 
 Polybrene  Sigma 
 L-Arginine:HCL (13C6) Cambridge Isotope Laboratories  
 L-Lysine:2HCL (4,4,5,5-D4) Cambridge Isotope Laboratories  
 NP-40 (IGEPAL CA-630) Sigma-Aldrich 
 NuPAGE LDS sample buffer (4X) Invitrogen  
 NuPAGE sample reducing buffer 
(10X) 
Invitrogen 
 PP1 inhibitor Calbiochem 
 Prestained broad range protein 
marker (6.5-175 kDa)  
New England Biolabs 
 Prestained broad range protein 
marker (11-190 kDa)  
New England Biolabs 
 Protein AG-Agarose beads Santa Cruz Biotechnology 
 RPMI 1640 + Glutamax Gibco 
 SILAC RPMI 1640 Medium Thermo Scientific 
 Streptavidin-Sepharose beads GE Healthcare 
 Streptavidin APC BD Biosciences 
 Streptavidin HRP Southern Biotech 
 TransIT 293 Transfection 
Reagent 
Mirus 




5.1.13 Instruments and their supplier 
 
 LSRII Becton Dickinson 
 FACS Calibur 
 ChemoCam Imager 
Becton Dickinson 
Intas 
 NanoDrop 2000 Thermo Scientific 
 
5.1.14 Softwares and their source 
 
 Clone Manager SECentral 
 FlowJo 7.6.5 TreeStar 
 CellQuest Pro Becton Dickinson 
 BD FACSDIVA Becton Dickinson 
 Office for Mac 2011 Microsoft 
 Photoshop CS4 
 Corel Draw X5 
Adobe 
Corel Corporation 
 Image J National Institute of Health 
 Perseus 1.5.5.0 
 NCBI database 
 Clustal Omega alignment tool 
 Uniprot protein database 








5.2.1 Culturing mammalian cells 
 
All cell lines were maintained in R10 medium under optimal growth conditions of 37C and 
5% CO2. The B cell lines were passaged at a dilution of 1:5 for daily use. The adherent 
Plate-E cells were passaged by removing the medium, washing with 1 ml 1X PBS and 
incubating with 1 ml Trypsin-EDTA at 37C for 5 min. Then, 9 ml fresh R10 medium was 
added and the required number of Plat-E cells were seeded onto a new dish. 
 
5.2.2 Freezing and thawing of mammalian cells 
 
To freeze cells, about 5 million cells in R10 medium were harvested by centrifugation at 
300 g for 5 min at room temperature (RT) and the supernatant was discarded. The pellet 
was resuspended in 1ml freezing medium, transferred to a vial and kept on ice. Short term 
storage of cells was done at -80C and long term storage at -140C. Frozen vials were 
thawed in a 37C water bath, the culture was added to 10 ml R10 medium and the cells 
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were harvested at 300 g, RT, 5 min. The pellet was resuspended in 10 ml fresh R10 
medium and seeded onto a 10 cm dish. The culture was allowed to grow to a confluency 
of about 90% before use. 
 
5.2.3 Restriction enzyme digestion of DNA for cloning 
 
1-3 g of DNA was incubated with 0.5-1.0 l restriction enzyme and the respective 
NEBuffer in a total volume of 20 l adjusted with ddH2O at 37C for 3 hours or O/N. 
Vector preparations were treated with 1.5 l CIP for an additional 60 min to prevent vector 
re-ligation. The samples were then mixed with 1X DNA loading dye and run on an 
agarose gel and visualized using the Gel Imager. 
 
5.2.4 Agarose gel electrophoresis and purification of DNA fragments 
 
Size based separation of DNA fragments was done using agarose gel electrophoresis. 
Depending on the size of the DNA fragment to be separated, a range of 1-2% agarose 
gels containing 0.1% (v/v) Ethidium bromide were cast and arranged in a chamber 
containing 1X TAE running buffer. The DNA samples were mixed with 1X DNA loading 
dye and loaded alongside 10 l of the 1 Kb DNA ladder. Electrophoresis was performed 
at 1.2 V/cm2 and the DNA bands were visualized under ultraviolet light using the Gel 
Imager. The required DNA bands were excised from the agarose gel and purified using 
the Promega Wizard® SV Gel and PCR Clean-Up System as per manufacturer’s protocol. 
The DNA was normally eluted in 20 l ddH2O. 
 
5.2.5 Ligation of DNA fragments 
 
Ligation of inserts into the preferred vectors was done by mixing 3 g Insert, 1 g vector, 
1 l T4 DNA ligase enzyme and 1 l 10X T4 ligase buffer. The final reaction volume was 
adjusted to 10 l with ddH2O and the ligation performed at RT for 1 hour or at 14C O/N. 1 
l of the ligation mix was transformed into competent bacterial cells and plated on LB agar 
plates containing 100 g/ml ampicillin (LB-Amp). 
 
5.2.6 Transformation of plasmid DNA into competent bacterial cells 
 
TOP10F’ and BL21 bacterial strains were made competent using the CaCl2 method 
described in Inoue et al 1990 and stored at -20C. A 50 l aliquot of competent cells was 
thawed and incubated with 1 l of the ligation reaction or 50 ng plasmid DNA for 20 min 
on ice. After heat shock at 42C for 42 sec, the cells were immediately put on ice for 2 
min. The cells were then directly plated onto a LB-Amp agar plate and incubated O/N at 
37C for colonies to grow. Alternatively, 5 l of the transformation mix containing a 
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previously sequenced clone was used to directly inoculate 6 ml liquid LB-Amp to grow an 
O/N culture for plasmid purification. 
 
 
5.2.7 Mini- and midi-preparations of plasmid DNA  
 
For small scale (mini) plasmid DNA preparation, 6 ml LB-Amp was inoculated with a 
colony and grown O/N at 37C and 200 rpm agitation speed. For large scale (midi) 
preparations 50 ml O/N cultures were used.  The cultures were then used for plasmid 
DNA purification using the Qiagen QIAprep Spin Miniprep kit or Qiagen HiSpeed 
Plasmid Midi kit as per the manufacturer’s protocol and DNA eluted in 30 l or 100 l 
ddH2O respectively.  
 
5.2.8 Analyzing DNA quality and sequence 
 
1 l DNA was used to measure optical density at 260 nm at the NanoDrop 2000 (Thermo 
scientific) and an optical density of 1.0 was quantified as 50 g/ml DNA. A sequencing 
reaction was setup by taking 1200 ng of purified DNA, 3 M primer and the volume 
adjusted to 15 l with ddH2O. Sequencing was done by SEQLAB Sequence Laboratories 
Goettingen GmbH. All DNA preparations were stored at 4C for short periods and at -
20C for long term storage. 
 
5.2.9 Polymerase chain reaction (PCR) 
 
The master mix was prepared as described below and split into two 25 l reactions for the 
PCR. One containing 1 l Phusion polymerase and the other without Phusion polymerase 
to serve as negative control. The PCR products were run on an agarose gel and further 
purified as described before. 
 
Master mix  
Ingredient Amount  
ddH2O 36 µl 
5X Phusion buffer 10 µl 
10 mM dNTPs 1 µl 
100 ng/µl Template DNA 1 µl 
10 µM Primer Fwd 1 µl 
10 µM Primer Rev 1 µl 








Temperature  Time  
94C 2 min 
94C 30 sec 
55C 1 min 
68C 30 sec per 1 kb plasmid 
68C 4 min final extension 
4C End 
 
5.2.10 Site directed mutagenesis  
 
For introduction of specific mutations in the DNA sequence, amplification of the entire 
plasmid DNA was done using complementary primers that contained the required 
mutation. The master mix was prepared as described below and split into two 50 l 
reactions for the PCR. One containing 1 l Pfu polymerase and the other without Pfu 
polymerase to serve as negative control.  
 
Master mix  
Ingredient Amount 
ddH2O 82 µl 
10X Pfu Buffer 10 µl 
10 mM dNTPs 2 µl 
100 ng/µl Template DNA 2 µl 
10 µM Primer Fwd 2 µl 
10 µM Primer Rev 2 µl 
Total 100 µl 
 
PCR cycle 
Temperature  Time  
94C 2 min 
94C 30 sec 
55C 1 min 
68C 2 min per 1 kb plasmid 
68C 10 min final extension 
4C End 
 
The reactions were then further divided into two aliquots of 25 l each. One was loaded 
on an agarose gel for visualization and the other was incubated with 1 µl DpnI at 37°C for 
1 hour. The DpnI cleaves the template plasmid which is methylated and leaves the PCR 
product intact. The product was then used directly for transformation into competent 
bacteria for further purification followed by quality and sequence tests.  
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5.2.11 TA cloning 
 
PCR products were cloned into the pCR2.1 vector using the TA cloning kit from 
Invitrogen. To add 3’ deoxyadenosine overhangs, 20 l of the purified PCR product was 
mixed with 2 l 10X Taq polymerase buffer, 1 l dATPs, 1 l Taq polymerase and 
incubated at 70C for 25 min. The product was then ligated as described in section 5.2.5 
with the pCR2.1 vector containing 3’ deoxythymidine overhangs. Agar plates containing 
50 l X-gal (50 mg/ml stock) and 50 l IPTG (0.1 M stock) were plated with 1 l of the 
ligation product for examining successful ligation by blue-white screening. 
 
5.2.12 Retroviral transduction of B cells 
 
Retroviral transduction was done using the ecotropic Plat-E retroviral packaging cell line 
which produces viruses carrying the DNA of interest. Viral particles produced by the Plat-
E’s were used to infect B cells that carried the murine ecotropic receptor for viral particle 
recognition. For cells that did not carry the ecotropic receptor, the transfection solution 
was mixed with the packaging vector pCMV-VSV-G which enables infection of human 
cells via the vesicular stomatis virus-glycoprotein. To this end, the adherent Plat-E cells 
were grown to about 60% confluence on a 6 cm dish. The medium was carefully replaced 
with 3 ml fresh R10 (pre-warmed to 37C), the transfection solution added and the culture 
grown at 37C O/N. The transfection solution was prepared as follows: 
 250 l R0 at 37C 
 Add 8 l TransIT, mix well and incubate at RT for 15 min 
 Add 3 g DNA, mix well and incubate at RT for 20 min (0.5 g pCMV-VSV-G 
included if required) 
The next day, 3 ml fresh R10 (pre-warmed to 37C) was added and the culture grown at 
37C O/N. The supernatant was carefully collected after centrifugation and the Plat-E cells 
pelleted by centrifugation at 300g at RT for 5 min. About 4 ml of the supernatant was used 
to infect about 2 million B cells along with 4 g/ml Polybrene solution. The cells were 
grown at 37C and to obtain a nearly confluent 10 cm dish. The cells were then put under 
selection with 3 g/ml puromycin. After at least 7 days of selection, the efficiency of 
infection was analyzed using flow cytometry for cell surface proteins. Alternatively, cells 
that did not carry selection markers or underwent incomplete selection were sorted via 
fluorescent activated cell sorting (FACS). 
 
5.2.13 Cell sorting 
 
Cells were sorted by FACS at the Cell Sorting Facility of the University Medical Center 
Goettingen with the technical assistance of Sabrina Becker. Approximately 5-7 million 
cells were washed and stained with fluorescently labeled antibodies against surface 
proteins whereas GFP/RFP positive cells were simply washed and finally resuspended in 
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500 l 1X PBS for cell sorting. Sorted cells were collected in R10 medium, washed twice 
in R10 medium before resuspension in 200 l R10 in 96 well round bottom plates. Cells 
were grown at 37C and slowly expanded for use and storage. 
 
 
5.2.14 Surface staining and protein expression analysis via flow cytometry 
 
Surface expression of proteins was measured using fluorescently labeled antibodies 
against the protein of interest. 1 million cells were harvested at 300 g, 4C for 5 min and 
washed once in 1X PBS. The cell pellet was dissolved in 100 l 1X PBS and 1 l of the 
fluorescently labeled antibody was added to the solution, vortexed and incubated on ice 
for 10 min protected from light. The cells were washed with 1X PBS and the pellet 
dissolved in 300 l 1X PBS for measurement at the FACS calibur or BD LSRII. Stained 
untransfected cells or unstained cells were used as negative controls to measure 
background fluorescence. Cells expressing GFP and/or RFP were washed once in 1X 
PBS and resuspended in 300 l 1X PBS for measurement. Data was acquired using the 
CellQuestPro or FACSDIVA software’s and data was processed with FlowJo and 
Microsoft PowerPoint. 
 
5.2.15 Preparation of B cell lysates  
 
B cells were grown to about 70% confluency and harvested by centrifugation at 300 g, RT 
for 5 min. The cell pellet was resuspended in 1X PBS and the cells were counted using a 
hemocytometer. The cells were harvested, resuspended in 10 ml R0 and starved for 30 
min at 37C with regular mixing. The cells were harvested again and resuspended in 200 
l R0 per 5 million cells and stimulated with the appropriate anti-BCR antibody for the 
stipulated time points or left untreated in the case of unstimulated samples. The cell pellet 
was harvested in the minicentrifuge at 2000g for 10 sec, the media removed completely 
and the cells lysed in 20 l B cell lysis buffer (1% NP40 detergent) per 1 million cells. 
Lysis was performed on ice for 10 min and the cell debris pelleted at 20000 g, 4C for 10 
min. The supernatant comprising the cell lysate was separated and mixed 1:1 with 2X 
laemlli buffer, boiled at 95C for 5 min and 40 l (1 million cell lysates) sample was 
analyzed by SDS-PAGE and immunoblotting. Lysates boiled in laemlli were stored at -




Size based separation of proteins was done using standard SDS-PAGE. A 10% 
polyacrylamide resolving gel and 5% polyacrylamide stacking gel was used. The gels 
were cast and run in 1X SDS running buffer using the Hoefer SE600 Ruby system by GE 
Healthcare. Samples were prepared by boiling in laemlli buffer at 95C for 5 min and 
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loaded onto the gel alongside a protein ladder. The separating gel was run at 25 mA, 250 
V and the resolving gel at 35 mA, 250 V. For the detection of GST fusion proteins, the 
mini gel system from BioRad was utilized with the same gel composition as mentioned 
above. The mini gel was run at 15 mA, 250 V for the separating gel and 20 mA, 250 V for 
the resolving gel. 
 
5.2.17 Immunoblotting / western blotting 
 
The detection of specific proteins that were separated by SDS-PAGE was carried out by 
immunoblotting and detection via ECL. The blotting chamber was placed with the anode 
at the bottom followed by a layer of whatman paper, nitrocellulose membrane, the gel,  
and another layer of whatman paper, all pre-soaked in blotting buffer. The excess liquid 
along with the air bubbles carefully removed by applying pressure with a rolling glass rod. 
The cathode was placed on top and protein transfer carried out at 16 V, 240 mA for 70 
min. The membrane was then washed in 1X TBST (used as wash buffer) and blocked at 
room temperature for 60 min with blocking solution. The membrane was washed again 
and incubated O/N with the primary antibody. The membrane was then washed for 5 min, 
incubated with Horse radish peroxidase (HRP) labeled secondary antibody for 60 min and 
washed thrice for 15 min each before ECL-mediated detection. An ECL solution was 
prepared with 4 ml ECL solution A, 1.2 l H2O2 and 400 l ECL solution B and poured 
over the membrane. The light generated by excitation of oxidized luminol by the HRP was 
detected using the ChemoCam Imager, Intas. The blot images were processed in 
Photoshop CS4 and CorelDraw and blot quantification was done using ImageJ and 
Microsoft Excel. The quantified values were normalized by setting the highest value to 1.0. 
 
5.2.18 Affinity purification using antibodies or biotinylated peptides 
 
B cells were grown to about 70% confluency and harvested at 300 g, RT for 5 min. The 
cell pellet was resuspended in 1X PBS and the cells were counted. The cells were 
harvested, resuspended in 10 ml R0 and starved for 30 min at 37C with regular mixing. 
30 million cells per sample were resuspended in 500 l R0 and stimulated with anti-BCR 
antibodies for the stipulated time points or left unstimulated. The cells were harvested in 
the minicentrifuge at 2000 g for 10 sec, washed once with 1X PBS and then lysed with 
600 l lysis buffer on ice for 10 min. The cell debris were pelleted at 20000 g, 10 min, 4C 
and the cell lysates were incubated with 2 g of the purifying antibody and 30 l Protein 
AG-Agarose beads for 2 hours at 4C with constant rotation. The beads were then 
washed thrice with lysis buffer at 500 g, 4 min, 4C. The beads were mixed with 30 l 2X 
laemlli and boiled at 95C for 5 min. The samples were analyzed by SDS-PAGE and 
immunoblotting. In case of purification of proteins that associate with the phospho-IgE-
ITT, the cell lysates from anti-human-IgE stimulated DG75 B cells were incubated with 1 
M of the biotinylated peptide and 30 l streptavidin beads for 2 hours at 4C with 
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constant rotation. The beads were then washed thrice with lysis buffer at 500 g, 4 min, 
4C. The beads were mixed with 30 l 2X laemlli and boiled at 95C for 5 min. The 
samples were analyzed by SDS-PAGE and immunoblotting. 
 
5.2.19 BCR purification 
 
B cells were grown to about 70% confluency and harvested at 300 g, RT for 5 min. The 
cell pellet was resuspended in 1X PBS and the cells counted. The cells were harvested, 
resuspended in 20 ml R0 and starved for 30 min at 37C with regular mixing. In Fig. 4, 70 
million cells per sample were resuspended in 1 ml R0 and either left untreated or treated 
with 30 M PP1 or 30 M Bay61-3606 for 30 min. They were then stimulated with 10 
g/ml anti-human-IgE-Biotin antibody for 3 min or left unstimulated at 37C. The cells 
were harvested in the minicentrifuge, washed once with 1X PBS and then lysed with 600 
l lysis buffer on ice for 10 min. 10 g/ml anti-human-IgE antibody was added to the 
unstimulated samples after cell lysis. For purification of surface BCRs in Fig. 18, 30 million 
cells were treated with 10 g/ml anti-human-IgE-Biotin antibody or 20 g/ml anti-human-
IgM-Biotin on ice for 5 min. The cells were harvested in the minicentrifuge, washed 
thoroughly twice with 1X PBS and then lysed with 600 l lysis buffer on ice for 10 min. In 
each case, the cell debris were pelleted at 20000 g, 10 min, 4C and the cell lysates were 
incubated with 30 l streptavidin beads for 2 hours at 4C with constant rotation. The 
beads were then washed thrice with lysis buffer at 500 g, 4 min, 4C. The beads were 
mixed with 30 l 2X laemlli and boiled at 95C for 5 min. The samples were analyzed by 
SDS-PAGE and immunoblotting. 
 
5.2.20 Isolation of GST fusion proteins 
 
BL21 cells were transformed with the pGEX4T-1 vector containing the Grb2 and Grap 
SH2 domains. Glycerol stocks were prepared by mixing glycerol and a O/N culture in 1:1 
ratio and kept at -80C for long term storage. The glycerol stock was thawed and 1 l 
each was used to inoculate two 6 ml cultures grown O/N at 37°C in LB-Amp. These were 
then added to 90 ml LB-Amp pre-warmed to 37°C and further incubated at 37C. The 
starting optical density at 600 nm was measured and tracked to reach a value of 0.6 at 
which point protein expression was induced with 0.1 µM IPTG for 4-5 hours at 25°C. 25 ml 
culture aliquots were used to harvest bacterial pellets at 2500 g, 15 min, RT. The pellets 
were frozen at -80°C for up to 6 months. The frozen pellet was thawed on ice, 
resuspended in 10 ml PBS and lysed by sonication thrice at 30 sec, 40% power, 50% 
cycle followed by treatment with 0.1% TritionX-100 for 20 min on ice. The cell debris was 
pelleted at 1500 g, 35 min, 4C and the supernatant incubated with a 50% slurry of 200 l 
glutathione sepharose beads on a rotator at 4C for 2 hours. The beads were then 
washed thrice at 500 g, 4 min, 4C with 1X PBS, leaving about 100 l 1X PBS over the 
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beads and stored at 4C for up to 10 days. To check for amount of purified GST fusion 
protein, different volumes were boiled with laemlli buffer at 95C for 5 min, loaded onto a 
10% mini-gel along with titrated amounts of BSA. The gel was stained with coomassie 
solution for 30 min and destained in water O/N. The GST fusion protein concentration was 
calculated based on comparison of band intensity with the BSA standard.  
 
5.2.21 Affinity purification using GST fusion proteins 
 
B cells were grown to about 70% confluency and harvested at 300 g, RT for 5 min. The 
cell pellet was resuspended in 1X PBS and the cells were counted. The cells were 
harvested, resuspended in 10 ml R0 and starved for 30 min at 37C with regular mixing. 
30 million cells per sample were resuspended in 500 l R0 and stimulated with anti-BCR 
antibodies for the stipulated time points or left unstimulated. The cells were harvested in 
the minicentrifuge, washed once with 1X PBS and then lysed with 600 l lysis buffer on 
ice for 10 min. The cell debris was pelleted at 20000 g, 10 min, 4C and the cell lysates 
were incubated with 15 g GST-fusion protein and 30 l glutathione sepharose beads for 
2 hours at 4C with constant rotation. The beads were then washed thrice with lysis buffer 
at 500 g, 4 min, 4C. The beads were mixed with 30 l 2X laemlli and boiled at 95C for 5 
min. The samples were analyzed by SDS-PAGE and immunoblotting. 
 
5.2.22 Ca2+ measurements 
 
For monitoring Ca2+ flux following BCR stimulation, the Ca2+ indicator Indo1-AM, which is 
an acetoxymethyl ester of the fluorescent dye Indo1 was used. The dye enters the cells 
when uncharged, gets cleaved by intracellular esterase’s to become charged and hence is 
trapped in the cells. Binding of Ca2+ to the dye leads to a shift in its emission spectra from 
530 nm to 405 nm and hence gives a measure of changes in intracellular Ca2+ levels. The 
cells were grown to a confluency of about 70% to minimize pre-activation. 1 million cells 
per measurement were harvested at 300g, RT for 5 min and each set of samples was 
resuspended in 500 l R10. The cells were transferred to a light protected eppendorf and 
a staining mix consisting of 200 l R10, 0.7 l Indo-1 AM (1 mM stock in DMSO) and 2 l 
Pluronic acid F-217 (5% stock) was added to the tube. The tube was vortexed for 5 sec 
and kept on the thermomixer for 30 min at 30C and 600 rpm. The cells were then 
washed twice in Krebs Ringer solution (pre-warmed to RT) at 300 g, RT for 2 min and 
finally resuspended in 300 l Krebs Ringer solution per million cells. The cells were 
incubated at 30C at 300 rpm for 30 min on the thermo mixer for revival. For the 
measurement, a basal Ca2+ level was measured for 30 sec after which the sample was 
stimulated with the anti-BCR antibodies. Measurements were done at the LSRII, data 
acquisition using FACSDIVA and data analysis using FlowJo and Microsoft Excel. 
 
5.2.23 Mass spectrometry 




The human mIgE-ITT interactome was elucidated by purifying interaction partners form 
SILAC labeled B cells. All reagents and flasks used for the experiment were autoclaved or 
sterile packaged to prevent and dust contamination. Wild-type DG75 B cells were grown 
in “Heavy” or “Light” SILAC medium for 1 week for incorporation of the amino acid labels. 
The “Heavy” label contained L-Arginine (13C6) and L-Lysine (D4) whereas the light label 
had these amino acids in their normal molecular weight. The cells were expanded to 
about 70% confluency and harvested at 300 g, RT for 4 min. The cell pellet was 
resuspended in 1X PBS and the cells were counted. The cells were harvested and 150 
million cells per sample were lysed with 3 ml lysis buffer (1% NP40) on ice for 15 min. The 
cell debris was pelleted at 20000 g, 10 min, 4C and the cell lysates were incubated with 1 
M of the biotinylated peptide. The “Heavy” labeled cells were treated with 1 M human--
phospho-ITT peptide whereas the “Light” labeled cells were treated with 1 M non-
phosphorylated human--ITT peptide. 200 l streptavidin beads were added and the 
samples were incubated for 3 hours at 4C with constant rotation. The beads were then 
washed thrice with lysis buffer at 500 g, 4 min, 4C. In the end, both samples were 
combined and mixed with 120 l 1X LDS boiling buffer (prepared from stock solutions of 
10X NuPAGE sample reducing buffer and 4X NuPAGE LDS sample buffer in ddH2O) and 
boiled at 95C for exactly 5 min. The beads were spun down in the minicentrifuge at 
2000g for 15 sec and the supernatant was carefully removed and sent for mass 
spectrometry analysis to the Proteomics Core Facility at the University Medical Center 
Goettingen. There, the sample was size separated using SDS-PAGE and 23 gel bands 
encompassing the entire interactome were treated and analyzed by tandem mass 
spectrometry-MS/MS. The data was initially processed by the core facility and later by me 
using the Perseus software. In Perseus, the log2 transformed values of Heavy/Light (H/L) 
normalized ratio and log10 transformed values of intensity were created. The data was 
then filtered using the Significance B function and the scatter plot was generated. The 
proteins that had a H/L normalized ratio of more than 2.0 were considered to be 
statistically relevant interaction partners of the human--phospho-ITT peptide. The scatter 
plot and list of enriched proteins were exported to CorelDraw for final processing. 
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This was one of the first descriptions of the interaction between a toxin and an antitoxin 
(antibody). It was also the very first time that a mechanism involving a ligand and a ligand-
specific receptor was proposed, a finding that also proved relevant for other fields of 
biology besides immunology. The so-called side-chain theory led to the awarding of the 
1908 Nobel Prize in Physiology or Medicine to Paul Ehrlich. It is fascinating that Ehrlich 
not only correctly hypothesized the presence of a membrane-bound toxin-specific 
antitoxin, but also that binding of the toxin leads to activation of the cell and secretion of 
the very same antitoxin into the serum, providing long term protection. We now know this 
process as antigen-induced BCR signaling which can result in differentiation of B cells into 
antibody-secreting plasma cells.  
 
It has been about 116 years since this model was first proposed. We have come a long 
way since then and our knowledge into antibody structure and function is now 
successfully applied in the clinics to specifically target molecules and cure diseases. 
However, despite the extensive progress in our understanding of antibodies, there are still 
new things to learn and discover about these molecules. This is something that inspires 
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